View Day Schedule

Wednesday, November 17, 2010 Print Entire 2009 Program:
SESSION 1 SCHEDULE
Wednesday SESSION 1: HEMODIALYSIS ACCESS - PART 1 (8-MINUTE TALKS) Moderators:TBD
x
7:55 AM - 8:00 AM	Introduction

PART 1A: INTERVENTIONAL PROCEDURES FOR HEMODIALYSIS ACCESS
Moderator(s): TBD / TBD
8:00 AM - 8:08 AM	Physical Examination Of The Vascular Access

8:09 AM - 8:17 AM	Ultrasound Guided Access Interventions

8:18 AM - 8:26 AM	Angiographic Evaluation And Management Of Poorly Functioning Fistulas

8:27 AM - 8:35 AM	Primary Stenting Of Venous Anastomotic Stenoses

8:36 AM - 8:44 AM	Implications Of High Radial Artery Takeoff In Vascular Access

8:45 AM - 8:53 AM	Enhancement Of Fistula Maturation

8:54 AM - 9:02 AM	Pathophysiology Of Vein Injury During Fistula Maturation

9:03 AM - 9:11 AM	Salvaging The Unsalvageable Fistula

9:12 AM - 9:20 AM	Percutaneous Ligation Of Accessory Veins

9:21 AM - 9:29 AM	Incisional Thrombectomy

9:30 AM - 9:38 AM	Percutaneous Management Of High-Flow Fistulas

9:39 AM - 10:00 AM	Panel Discussion
10:00 AM - 10:20 AM	Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
PART 1B: CLINICAL PRACTICE ISSUES
Moderator(s): TBD / TBD
10:20 AM - 10:28 AM	Pre-Procedural Laboratory Studies

10:29 AM - 10:37 AM	Radiation Safety During Fluoroscopy

10:38 AM - 10:46 AM	Management Of Contrast Allergies

10:47 AM - 10:55 AM	Alternative Contrast Agents For Fistulography

10:56 AM - 11:04 AM	Management Of Pulmonary Embolism During AV Access Interventions

11:05 AM - 11:13 AM	AV Fistula Toxicity

11:14 AM - 11:22 AM	National Database For Vascular Access Procedures

11:23 AM - 11:31 AM	Simulator Training For Vascular Access Interventions

11:32 AM - 11:50 AM	Panel Discussion
11:50 AM - 12:45 PM	Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 1

SESSION 2 SCHEDULE
Wednesday SESSION 2: HEMODIALYSIS ACCESS - PART 2 (8-MINUTE TALKS) Moderators:TBD
x
PART 2A: HEMODIALYSIS CATHETERS AND CENTRAL VEINS
Moderator(s): TBD / TBD
12:45 PM - 12:53 PM	Hemodialysis Catheter Complications: We Can Do Better

12:54 PM - 1:02 PM	Hemodialysis Catheter Insertion: Single Incision Technique

1:03 PM - 1:11 PM	Central Venous Anatomy

1:12 PM - 1:20 PM	Individualized Strategies For Successful Management Of Central Venous Stenosis

1:21 PM - 1:29 PM	Percutaneous Management Of Central Venous Stenoses

1:30 PM - 1:38 PM	Surgical Management Of Central Venous Occlusion

1:39 PM - 1:47 PM	HeRo Device: Indications And Outcomes

1:48 PM - 2:10 PM	Panel Discussion
PART 2B: NEW TECHNOLOGY
Moderator(s): TBD / TBD
2:10 PM - 2:18 PM	Does Integrated Ringed Support Benefit Dialysis Access Grafts?

2:19 PM - 2:27 PM	Clinical Experience With A Self-Sealing Vascular Graft For Early Cannulation

2:28 PM - 2:36 PM	Initial Experience With A Unique A-V Graft Designed To Minimize Venous Outflow Complications

2:37 PM - 2:45 PM	Improved Hemodynamics With The Gore Hybrid Vascular Access Graft

2:46 PM - 2:54 PM	AV Fistula Creation Using The Optiflow Vascular Anastomosis Device

2:55 PM - 3:03 PM	Use Of Viabahn Stent Grafts For Vascular Access Creation

3:04 PM - 3:12 PM	Clinical Experience With The Spiral Flow Vascular Access Graft

3:13 PM - 3:30 PM	Panel Discussion
3:30 PM - 3:50 PM	Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
PART 2C: UPDATE ON SURGICAL PROCEDURES IN HEMODIALYSIS ACCESS
Moderator(s): TBD / TBD
3:50 PM - 3:58 PM	Update On Outcomes Of Fistula vs. Graft For Hemodialysis Access

3:59 PM - 4:07 PM	Secondary Fistulas

4:08 PM - 4:16 PM	Vascular Access In The Morbidly Obese Patient

4:17 PM - 4:25 PM	Use Of Ultrasound Guided Liposuction For Superficialization Of AV Fistulas

4:26 PM - 4:34 PM	New Techniques To Maintain Vascular Access Sites

4:35 PM - 4:43 PM	Surgical Management Of The Aneurysmal Fistula

4:44 PM - 4:52 PM	Banding vs. DRIL vs. Proximalization For Treatment Of Steal Syndrome

4:53 PM - 5:10 PM	Panel Discussion
5:10 PM - 5:10 PM	Hemodialysis Access Program Adjourns
END OF SESSION 2

SESSION 3 SCHEDULE
Wednesday SESSION 3: NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE (PART 1) Moderators:TBD
x
9:50 AM - 10:00 AM	Introduction

Moderator(s): TBD / TBD
10:00 AM - 11:00 AM	Case Presentations And Audience Discussion
11:00 AM - 11:15 AM	Why Do Dissections Occur?

11:15 AM - 11:30 AM	Classification System

11:30 AM - 12:00 PM	Genetics Of Aortic Aneurysm Disease

12:00 PM - 12:45 PM	Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 3

SESSION 4 SCHEDULE
Wednesday SESSION 4: NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE (PART 2) Moderators:TBD
x
PART 2A: RESIDUAL ARCH DISSECTION MANAGEMENT
Moderator(s): TBD
12:45 PM - 1:15 PM	Case Presentations
1:15 PM - 1:30 PM	The Gold Standard For Acute Proximal Dissections: Conventional Operative Approach – Is There A Reason To Evolve?
	Presenters(s):Joseph S. Coselli, MD
1:30 PM - 1:45 PM	Debate: Arch Repair Should Be Done At The Time Of Initial Ascending Repair

1:45 PM - 2:00 PM	Debate: Arch Repair Should Not Be Done At The Time Of Initial Ascending Repair

2:00 PM - 2:15 PM	Malperfusion After Proximal Dissections

2:15 PM - 2:30 PM	ETG Procedure For Chronic Dissection

2:30 PM - 2:45 PM	Hybrid Arch Repair Outcomes

2:45 PM - 3:15 PM	Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
PART 2B: CHRONIC DISTAL DISSECTION
Moderator(s): TBD / Richard P. Cambria, MD
3:15 PM - 3:45 PM	Case Presentations
3:45 PM - 4:00 PM	Follow-up Paradigms For Stable Aortic Dissection: Objectives, Goals And Scientific Evidence

4:00 PM - 4:15 PM	Review Of Published Outcomes Of Surgical Repair Of Chronic Dissection

4:15 PM - 4:30 PM	Review Of Published Outcomes Of Endovascular Repair Of Chronic Dissection

4:30 PM - 4:40 PM	Debate: Is There A Role For Endovascular Repair Of Chronic Dissections: Stent Graft To The Celiac

4:40 PM - 4:50 PM	Debate: Is There A Role For Endovascular Repair Of Chronic Dissections: Total Aortic Repair With Branched Graft

4:50 PM - 5:00 PM	Debate: Is There A Role For Endovascular Repair Of Chronic Dissections: Endovascular Repair Of Chronic Distal Dissections Is Heresy
	Presenters(s):Hazim J. Safi, MD
5:00 PM - 5:15 PM	Spinal Cord Ischemia: Are There Specific Dissection Issues?

5:15 PM - 5:15 PM	Adjourn for the day. New Horizons in Cardiovascular Surgery continues on Thursday morning in the Grand Ballroom, 3rd Floor.
END OF SESSION 4

SESSION 5 SCHEDULE
Wednesday SESSION 5: ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 1 (9-MINUTE TALKS) Moderators: / TBD
x
8:00 AM - 8:09 AM	Welcome – Endovascular Venous Surgery At A Glance

8:10 AM - 8:19 AM	How Should We Approach The “Comparative Effectiveness” Issue? Do Our Interventions Affect The Progression Of Disease? Can The Registries Organized By The American Venous Forum Help?

8:20 AM - 8:29 AM	Accepted Anatomical Nomenclature And Preoperative Duplex Mapping

8:30 AM - 8:39 AM	Debate – Pro: The Origin Of Saphenous Reflux Is Descending (Traditional Theory)

8:40 AM - 8:49 AM	Debate – Con: The Origin Of Saphenous Reflux Is Descending (Traditional Theory)

8:50 AM - 8:59 AM	Endovenous Thermal Ablation: Technical Pearls For Great And Small Saphenous Trunks

9:00 AM - 9:09 AM	Endovenous Thermal Ablation: Technical Pearls For Complex Anatomy

9:10 AM - 9:19 AM	Can Saphenous And Sural Nerve Paresthesia Be Prevented?

9:20 AM - 9:29 AM	Technical Pearls For Optimizing Sclerotherapy

9:30 AM - 9:39 AM	Technical Pearls For Optimizing Office-Based Phlebectomy

9:40 AM - 9:49 AM	Which One: Phlebectomy, Trivex, Or Sclerotherapy For Bulging Varicose Vein Tributaries?

9:50 AM - 9:59 AM	Should Adjuvant Procedures Be Performed At The Same Time As Endothermal Ablation? Evidence Based

10:00 AM - 10:09 AM	Review Of Randomized Controlled Trials Comparing Endovenous Thermal Ablation With Modern Extirpation Surgery For Saphenous Incompetence

10:10 AM - 10:19 AM	Which Imaging Techniques Can Help Doctors Better Understand The Pathologic Relationships Between The Superficial And Deep Systems?

10:20 AM - 10:29 AM	Advanced Venous Disease? Think Pelvic Outflow Obstruction

10:30 AM - 10:39 AM	How To Treat Chronic Venous Obstructions At Inguinal Ligament Location: Should We Choose Endovascular Technique Or Surgical Technique?

10:40 AM - 10:49 AM	Other Pelvic Venous Syndromes

10:50 AM - 10:59 AM	5 Technical Pearls For Endovascular Venous Stenting

11:00 AM - 11:09 AM	Debate – Pro: Only C4, C5, C6 Refluxing Truncal Veins Indicate Medical Necessity; Thus An Insurance Covered Expense

11:10 AM - 11:19 AM	Debate – Con: Only C4, C5, C6 Refluxing Truncal Veins Indicate Medical Necessity; Thus An Insurance Covered Expense

11:20 AM - 11:29 AM	Natural History And Progression Of DVT: How To Prevent And Treat Post-Thrombotic Syndrome

11:30 AM - 11:39 AM	When To Place And Retrieve A Vena Cava Filter: Timing And Follow-up Strategy

11:40 AM - 11:49 AM	Why Vascular Surgeons Should Join The American Venous Forum

11:50 AM - 11:59 AM	Current Statistics From American Venous Forum Screening Program: If We Find More Disease Can Society Pay For It?

12:00 PM - 12:29 PM	Luncheon Panel
	Panelist(s): Jose I. Almeida, MD, FACS, RVT / Mark A. Adelman, MD / Anthony J. Comerota, MD, FACS, FACC / Bo G. Eklof, MD, PhD / David L. Gillespie, MD / Edward G. Mackay, MD / Mark H. Meissner, MD / Peter J. Pappas, MD / Eberhard Rabe, MD / Seshadri Raju, MD / Cees H.A. Wittens, MD, PhD
END OF SESSION 5

SESSION 6 SCHEDULE
Wednesday SESSION 6: ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 2 (9-MINUTE TALKS) Moderators: / TBD
x
12:30 PM - 12:39 PM	Venous Laser Updates: Long Wavelengths Allow Usage Of Less Power And Lower Energy Density

12:40 PM - 12:49 PM	Venous Laser Updates: New Fibers Allow Usage Of More Power And More Energy Density With Short Wavelengths

12:50 PM - 12:59 PM	Any Updates With Radiofrequency Thermal Ablation?

1:00 PM - 1:09 PM	Is There A Common Theme For Endovenous Thermal Ablation Failure?

1:10 PM - 1:19 PM	Foam Sclerotherapy: Is It Dangerous?

1:20 PM - 1:29 PM	Complications Of Foam Sclerotherapy: What I Have Witnessed And How To Avoid Them

1:30 PM - 1:39 PM	Using Different Gases For Foam Sclerotherapy: The Pros And The Cons

1:40 PM - 1:49 PM	Ileofemoral Deep Vein Thrombosis: Catheter-Directed Thrombolysis Or Pharmacomechanical Treatment?

1:50 PM - 1:59 PM	Thrombophilia For Dummies: When To Order? What To Order? How To Treat And For How Long?

2:00 PM - 2:09 PM	How To Treat Ascending GSV Superficial Thrombophlebitis

2:10 PM - 2:19 PM	Should We Treat Calf Vein DVT? Evidence Based

2:20 PM - 2:29 PM	Thrombus Extensions At The SFJ After Endovenous Thermal Ablation: Should We Worry?

2:30 PM - 2:39 PM	Recurrent Varicose Veins: Can They Be Prevented? Can They Be Treated Effectively?

2:40 PM - 2:49 PM	Are Perforating Veins Being Overtreated?

2:50 PM - 2:59 PM	Issues On Ulcer Healing

3:00 PM - 3:09 PM	Patient Satisfaction Depends On Proper Management Of Patient Expectations: Let’s Take Spider Telangiectasia Treatment For Example

3:10 PM - 3:19 PM	Randomized Trial Comparing RF, Laser, Foam Sclerotherapy And Stripping In Varicose Veins

3:20 PM - 3:29 PM	Pharmacomechanical Saphenous Vein Ablation: 1-Year Data

3:30 PM - 3:39 PM	Terminal Interruption Of The Reflulx Source: TIRS Technique For Venous Ulcers

3:40 PM - 4:00 PM	Ask The Panel
	Panelist(s): Jose I. Almeida, MD, FACS, RVT / Lowell S. Kabnick, MD, FACS, FACPh / Ronald G. Bush, MD / Anthony J. Comerota, MD, FACS, FACC / Alun H. Davies, MA, DM, FRCS, FHEA / Steve Elias, MD / Timothy K. Liem, MD / Edward G. Mackay, MD / William A. Marston, MD / Thomas F. O'Donnell, Jr., MD / Lars H. Rasmussen, MD, DMSc
3:45 PM - 4:00 PM	Adjourn. Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 6

SESSION 7 SCHEDULE
Wednesday SESSION 7: WOUNDS - PART 1 Moderators:TBD
x
8:00 AM - 8:10 AM	Opening Remarks

PART 1A: NEW CONCEPTS IN WOUND CARE
Moderator(s): TBD
8:10 AM - 8:20 AM	Treatment Of Pyoderma Gangraenosum With Immunosuppression And A Bi-Layered Skin Substitute

8:20 AM - 8:30 AM	Discussion
8:30 AM - 8:40 AM	Effectiveness, Tolerance And Safety Of Electrotherapy With The WoundEL System In Hard-To-Heal Wounds

8:40 AM - 8:50 AM	Discussion
8:50 AM - 9:00 AM	Treatment Of Split Thickness Skin Graft Donor Sites

9:00 AM - 9:10 AM	Discussion
9:10 AM - 9:20 AM	Role Of Keratinocytes In Healing Of Chronic Wounds

9:20 AM - 9:30 AM	Discussion
9:30 AM - 10:00 AM	Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
PART 1B: MEETINGS SUMMARY
Moderator(s): TBD
10:00 AM - 10:30 AM	Best From APWCA Meeting 2010

10:30 AM - 10:45 AM	Discussion
10:45 AM - 11:15 AM	Best From DFCON Meeting

11:15 AM - 11:30 AM	Discussion
PART 1C: WOUND HEALING SOCIETIES
Moderator(s): TBD
11:30 AM - 11:40 AM	Introducing The National Pressure Ulcer Advisory Panel (NPUAP)

11:40 AM - 11:50 AM	Discussion
11:50 AM - 1:00 PM	Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 7

SESSION 8 SCHEDULE
Wednesday SESSION 8: WOUNDS - PART 2 Moderators:TBD
x
PART 2A: EVIDENCE BASED MEDICINE IN WOUND CARE
Moderator(s): TBD
1:00 AM - 1:10 AM	Evidence Based Medicine In Vascular Surgery And Wound Care

1:10 PM - 1:20 PM	Discussion
1:20 PM - 1:30 PM	Threats Like Selection Bias And Performance Bias

1:30 PM - 1:40 PM	Threats Like Publication Bias And Citation Bias

1:40 PM - 2:00 PM	Discussion
2:00 PM - 2:10 PM	Improving Research In Wound Care

2:10 PM - 2:20 PM	RCT On Wound Care, With Good Randomization, Allocation Concealment And Blinding

2:20 PM - 2:30 PM	Patient Relevant Outcomes And Surrogate Outcomes

2:30 PM - 2:40 PM	Ischemic Wounds As An Endpoint In Clinical Trials

2:40 PM - 3:00 PM	Discussion
3:00 PM - 3:10 PM	Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
PART 2B: SPECIAL TOPICS OF INTEREST FOR THE VASCULAR SURGEON INVOLVED IN WOUND HEALING
Moderator(s): TBD
3:10 PM - 3:20 PM	Compression In Venous Leg Ulcers: How To Increase Patient Compliance

3:20 PM - 3:30 PM	Surgical Approach To Wounds Prior To Vascular Intervention: When Is It Indicated?

3:30 PM - 3:40 PM	Surrounding Skin Care In Vascular Ulcers

3:40 PM - 3:50 PM	Offloading: State-Of-The-Art

3:50 PM - 4:00 PM	Semmes Weinstein Monofilament: An Effective Screening Tool And Predictor Of Foot Ulceration And Amputation In Patients With Diabetes

4:00 PM - 4:10 PM	Perioperative Blood Sugar Control: Is Less More?

4:10 PM - 4:30 PM	Panel Discussion
PART 2C: VASCULAR INTERVENTIONS IN WOUND CARE
Moderator(s): TBD
4:30 PM - 4:40 PM	Debate: Diabetic Foot Ulcers: Surgical Bypass Is More Effective

4:40 PM - 4:50 PM	Debate: Diabetic Foot Ulcers: Endovascular Treatment Is More Effective

4:50 PM - 5:00 PM	Discussion
5:00 PM - 5:10 PM	Lifesaving Combination Of Vascular And Plastic Surgery For Treatments Of Large Tissue Defects In Cancer Patients

5:10 PM - 5:20 PM	Discussion
5:20 PM - 5:30 PM	Mixed Ulcers: Venous Ablation Or Arterial Reconstruction First?

5:30 PM - 5:40 PM	Discussion
5:40 PM - 5:50 PM	A New Minimally Invasive, Fast-Track Way To Compute Peripheral Vascular Anastomosis

5:50 PM - 6:00 PM	Discussion
6:00 PM - 6:10 PM	Closing Remarks

6:10 PM - 6:10 PM	WOUNDS Program Adjourns
END OF SESSION 8

SESSION 9 SCHEDULE
Wednesday SESSION 9: ACUTE STROKE MANAGEMENT - PART 1 Moderators:TBD
x
7:50 AM - 8:00 AM	Welcome And Introduction

PART 1A: THE BASICS: STROKE DIAGNOSIS AND MANAGEMENT FUNDAMENTALS
Moderator(s): TBD / TBD
8:00 AM - 8:10 AM	Stroke Classics: Correlating Clinical Presentation With Imaging: Highlighting The Cerebrovascular Territories

8:11 AM - 8:21 AM	TIAs - Transient Ischemic Attacks: Do We Need Better Classification And Treatment Triage Schemes?

8:22 AM - 8:32 AM	Hypoperfusion Syndromes: Diagnosis, Science, And Treatment Options

8:33 AM - 8:43 AM	Differential Diagnosis Of Stroke: How We Expedite The Diagnosis And Treatment Pathways

8:44 AM - 8:54 AM	Triage Is The Holy Grail; Door To Revascularization Time: What Is The Standard To Be Set?

8:55 AM - 9:10 AM	Discussion
PART 1B: STATE-OF-THE-ART IMAGING FOR CEREBROVASCULAR DISEASE AND STROKE
Moderator(s): TBD / TBD
9:11 AM - 9:21 AM	The Standard Neuroimaging Protocol: What , When And Why?

9:22 AM - 9:32 AM	Update On Latest Trials: Is There Any New Science To Guide Us On Which Patients Will Benefit From Revascularization?

9:33 AM - 9:43 AM	Debating The Pros And Cons Of CT(A/P) vs. MR(A/P)

9:44 AM - 9:54 AM	Stroke Imaging Pearls: Sequences To Help In Difficult Cases

PART 1C: STATE-OF-THE-ART TRIAGE FOR STROKE PATIENTS (5-MINUTE TALKS)
Moderator(s): TBD / TBD
9:55 AM - 10:00 AM	State-Of-The-Art Triage: My Best Asset Is The Clinical Exam

10:01 AM - 10:06 AM	State-Of-The-Art Triage: My Best Asset Is Neuroimaging

10:07 AM - 10:12 AM	State-Of-The-Art Triage: My Best Asset Is My Institution

10:13 AM - 10:30 AM	Discussion
10:30 AM - 11:00 AM	Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
PART 1D: ACCEPTANCE OF CAROTID STENTING OR IS IT MORE OF THE SAME?
Moderator(s): TBD / TBD
11:01 AM - 11:11 AM	CREST: What Are The Implications And Why?

11:12 AM - 11:22 AM	Symptomatic Carotid Disease: How I Choose Between CEA And CAS

11:23 AM - 11:33 AM	Asymptomatic Carotid Disease: When To Treat And Why

11:34 AM - 11:44 AM	Carotid Blowout Syndromes: Cancer To Trauma; Endovascular Options

11:45 AM - 12:00 PM	Discussion
PART 1E: BUILDING A COMPREHENSIVE STROKE CENTER: EXCELLENCE DEFINED BY TECHNOLOGY, MANPOWER, AND MANAGEMENT
Moderator(s): TBD / TBD
12:01 PM - 12:11 PM	Telemedicine: Its Role, Its Risk, And Its Intricacies

12:12 PM - 12:22 PM	Neurological Intensive Care: Best Practice, Benefits, And Cost; Defining A Standard!

12:23 PM - 12:39 PM	Discussion
END OF SESSION 9

SESSION 10 SCHEDULE
Wednesday SESSION 10: ACUTE STROKE MANAGEMENT - PART 2 Moderators:TBD
x
PART 2A: LUNCHEON SESSION: ACUTE STROKE TREATMENT OPTIONS 2010: INTRAVENOUS VS. INTRAARTERIAL - WHAT DO YOU PREFER?
Moderator(s): TBD / TBD
12:40 PM - 12:50 PM	Intravenous: Latest Guidelines

12:51 PM - 1:01 PM	Intraarterial Options: Are There Guidelines?

1:02 PM - 1:12 PM	Current IA Protocols For Reperfusion: Update

1:13 PM - 1:23 PM	Angioplasty, Stenting And Temporary Stenting: State-Of--The-Art Technology And Where We Are Headed

1:24 PM - 1:40 PM	Discussion
PART 2B: INTRACRANIAL ATHEROSCLEROSIS: DIAGNOSIS AND MANAGEMENT
Moderator(s): TBD / TBD
1:41 PM - 1:51 PM	Natural History Of Intracranial Atherosclerosis

1:52 PM - 2:02 PM	Therapeutic Options For Intracranial Stenosis: Medical, Interventional, And Surgical Guidelines

2:03 PM - 2:13 PM	SAMMPRIS Update

2:14 PM - 2:34 PM	Discussion
PART 2C: STROKE: HOT TOPICS AND CASE PRESENTATIONS WITH FIERCE DISCUSSION!
Moderator(s): TBD / TBD
2:35 PM - 2:45 PM	Slam Dunk IA Revascularization: The Case For The Pharmacologic Approach

2:46 PM - 2:56 PM	Slam Dunk IA Revascularization: The Case For Thrombectomy

2:57 PM - 3:07 PM	The Case I Should Not Have Chosen IA Therapy And Why: Identifying Nasty Anatomy And Pathology To Avoid

3:08 PM - 3:18 PM	Identifying Normal Vascular Anatomy And Staying Out Of Trouble In Acute Stroke

3:19 PM - 3:29 PM	Stroke Reimbursement: Is It Worth It?

3:30 PM - 3:40 PM	Stroke And tPA: The Legal Battles!

3:41 PM - 4:00 PM	Discussion
END OF SESSION 10

Thursday, November 18, 2010 Print Entire 2009 Program:
SESSION 11 SCHEDULE
Thursday SESSION 11: NEW DEVELOPMENTS IN ENDOVASCULAR HEART VALVES AND APPROACHES TO TREAT THORACIC AORTIC LESIONS (5-MINUTE TALKS) Moderators: / TBD
x
6:35 AM - 6:40 AM	Opening Remarks

6:40 AM - 6:45 AM	Direct Minimally Invasive Videoscopic Approach To The Thoracic Aorta For Delivery Of Aortic Endografts

6:46 AM - 6:51 AM	A New Embolic (Brain) Protection Device During Endovascular Aortic Arch And Valve Procedures To Prevent Strokes By Covering Orifices Of Supra-aortic Trunk

6:52 AM - 6:57 AM	Venous Trans-Septal Access To The Aorta And Its Branches: How Is It Done And When Can It Be Helpful?
	Presenters(s):Tilo Kölbel, MD, PhD
6:58 AM - 7:03 AM	Future Of Transcatheter Valves: What Will Be Left For Classical Operations: A Surgeon’s View

7:04 AM - 7:09 AM	Status Of Transcatheter Aortic Valve Repair: What Will Be Left For Classical Operations? A Cardiologist’s View

7:10 AM - 7:15 AM	Status Of Percutaneous Mitral Valve Repair: Have There Been Improvements In Devices And Techniques?
	Presenters(s):Ted Feldman, MD
7:16 AM - 7:21 AM	Intra-Thoracic Debranching Can Simplify The Approach To Type II Thoracoabdominal Aortic Aneurysms (TAAAs)

7:22 AM - 7:27 AM	Treatment Of Extensive Arch And Thoracic Aneurysms With Staged Open And Endograft Techniques Using The Evita Endograft: Revascularization Of Aortic Branches

7:28 AM - 7:33 AM	Overcoming The Challenge Of Thoracic Endograft Compression: Is Increased Radial Force The Answer?

7:34 AM - 7:44 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	11.1 - Laparoscopically Assisted TEVAR Via The Aorta Or Common Iliac Artery When Femoral And External Iliac Access Is Impossible
	Presenters(s):Ralf R. Kolvenbach, MD
Web-Based Presentation	11.2 - Primary And Secondary Aorto-Esophageal And Aortobronchial Fistulas And Their Modern Treatment

Web-Based Presentation	11.3 - Comparative Analysis Of Open And Endovascular Repair Of Ruptured Descending Thoracic Aortic Aneurysms (RTAAs)

Web-Based Presentation	11.4 - Neurological Complications Of TEVAR And Their Management: Paraplegia Is Reversible Whereas Stroke Is Not

Web-Based Presentation	11.5 - Is Spinal Ischemia With TEVAR More Of A Problem When Patients Have A Previous AAA Repair?

END OF SESSION 11

SESSION 12 SCHEDULE
Thursday SESSION 12: NEW DEVELOPMENTS IN TREATMENT OF THORACIC AND THORACOABDOMINAL AORTIC DISEASE (5-MINUTE TALKS) Moderators:Edward B. Diethrich, MD / TBD
x
7:45 AM - 7:50 AM	Simplified Arch Aneurysm Treatment With Fenestrated Endografts: How Can It Work And Initial Experience
	Presenters(s):Yoshihiko Yokoi, MD /
7:51 AM - 7:56 AM	Debate 1: New Developments In Branched And Fenestrated Endografts Suggest There Will Be No Role For Open Surgery In Repair Of TAAAs

7:57 AM - 8:02 AM	Debate 1: There Will Always Be A Role For Open Surgical Repair Of TAAAs Even With Improved Endografts

8:03 AM - 8:08 AM	Open And Endovascular Repair Of Descending Thoracic Aortic Aneurysms: There Is A Role For Both: What Is It?

8:09 AM - 8:14 AM	Exclusion Of Ascending Aorta And Aortic Arch Aneurysms Is Now Feasible By A Totally Endovascular Approach
	Presenters(s):Ralf R. Kolvenbach, MD
8:15 AM - 8:20 AM	Experience With A New Simplified Device To Treat Aortic Arch Aneurysms With Branched Endografts And Other Possible Future Designs

8:21 AM - 8:26 AM	Advances In In Situ Fenestration For Total Endovascular Arch Repair To Improve Branch Stability And Maintain Brain Perfusion During The Procedure
	Presenters(s):Bjõrn Sonesson, MD, PhD
8:27 AM - 8:32 AM	Debate 2: Properly Constructed Chimney Or Snorkel Grafts Can Work To Revascularize Aortic Arch Branches
	Presenters(s):Armando C. Lobato, MD, PhD
8:33 AM - 8:38 AM	Debate 2: Mechanical Stress And Strains On Branches In The Aortic Arch Mean Chimney Grafts Won’t Work Well Here

8:39 AM - 8:48 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	12.1 - A Novel More Effective Glue-Sealant (ArterX) For Hemostasis At Vascular Suture Lines And Other Sites

Web-Based Presentation	12.2 - New Hybrid Procedures For Ascending Aorta And Arch Reconstructions To Treat Difficult Aneurysms
	Presenters(s):Christoph A. Nienaber, MD, PhD
Web-Based Presentation	12.3 - In Situ Retrograde Arch Fenestration Techniques Are Going To Become Standard To Repair Arch Lesions: Current Technique And Experience

Web-Based Presentation	12.4 - Device Designs To Meet The Challenges Of The Aortic Arch

END OF SESSION 12

SESSION 13 SCHEDULE
Thursday SESSION 13: NEW DEVELOPMENTS IN STENT-GRAFTS, STENTS AND TECHNIQUES FOR TREATING THORACIC AORTIC LESIONS: MORE ABOUT COMPLICATIONS AND PATHOLOGY (5-MINUTE TALKS) Moderators: / TBD
x
8:49 AM - 8:54 AM	Pathogenesis, Prevention And Treatment Of Retrograde Type A Dissection After TEVAR And Open Surgery

8:55 AM - 9:00 AM	Perspective On The Causes, Prevention And Treatment Of Type A Dissections As A Complication Of TEVAR For Type B Dissections

9:01 AM - 9:06 AM	Endograft Treatment Of Type A Dissection: Real And Theoretical Systems Will Make This Feasible
	Presenters(s):Christoph A. Nienaber, MD, PhD
9:07 AM - 9:12 AM	Dynamic MR In Type B Dissections: Value In Determining Flap Mobility And Organ Perfusion; And In Guiding Treatment

9:13 AM - 9:18 AM	Indications, Techniques And Outcomes After Endovascular Treatment Of Chronic Type B Aortic Dissections In Patients With And Without Marfan’s Syndrome
	Presenters(s):Geoffrey H. White, MD
9:19 AM - 9:24 AM	Techniques For Endograft Treatment Of Dissecting Aortic Aneurysms Involving All Or Part Of The Arch: The "Miracle Technique" For Revascularization Of Arch Branches
	Presenters(s):Zaiping Jing, MD
9:25 AM - 9:30 AM	Update On The STABLE Trial With A Proximal Endograft And A Distal Uncovered Stent

9:31 AM - 9:36 AM	Improving Distal Fixation And Sealing In Thoracic Endografting With A Distal Graft Scallop For Visceral Arteries: Precautions And Results

9:37 AM - 9:42 AM	Strategies For Complex Hybrid Aortic Endografting
	Presenters(s):Edward B. Diethrich, MD
9:43 AM - 9:48 AM	Technique For Rapid Pacing And How It Helps In The Better Deployment Of Thoracic Endografts
	Presenters(s):Dietmar H. Koschyk, MD
9:49 AM - 9:55 AM	Panel Discussion
9:50 AM - 10:05 AM	Break / Visit Exhibits and Pavilions (2nd and 3rd Floors)
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	13.1 - Lessons Learned In 460 TEVARs: Mistakes That Can Be Avoided

Web-Based Presentation	13.2 - More Extensive Aortic Coverage By TEVAR In Type B Dissections Produces Better Outcomes
	Presenters(s):Matt M. Thompson, MD
Web-Based Presentation	13.3 - Endovascular Methods Other Than Endografts For Treating Thoracic Aortic Aneurysms

Web-Based Presentation	13.4 - Early Clinical Experience With Endovascular Treatment Of Type A Dissecting Aneurysms
	Presenters(s):Matt M. Thompson, MD
Web-Based Presentation	13.5 - Debate: Endovascular Treatment Of Uncomplicated Type B Aortic Dissection Is Beneficial

Web-Based Presentation	13.6 - Debate: Endovascular Treatment Of Uncomplicated Type B Aortic Dissection Is Not Beneficial

Web-Based Presentation	13.7 - Lessons Learned From Pathologic Exam After TEVAR Failure

END OF SESSION 13

SESSION 14 SCHEDULE
Thursday SESSION 14: LOWER EXTREMITY ENDOVASCULAR HOT TOPICS - PART 1 (5-MINUTE TALKS) Moderators: / TBD
x
6:40 AM - 6:45 AM	Opening Remarks

6:45 AM - 6:50 AM	Results With Jetstream Atherectomy/Thrombectomy In Infrainguinal Arterial Disease: What Makes It Different From Other Devices?

6:51 AM - 6:56 AM	Importance Of Embolization During Lower Extremity Endovascular Procedures: How Can It Be Prevented And Treated?

6:57 AM - 7:02 AM	The ANGIOSLIDE Balloon Catheter To Capture Embolic Material Released During Lower Extremity Angioplasty: A New Concept In Distal Embolic Protection

7:03 AM - 7:08 AM	Multicenter Belgian-Italian Trial Evaluating The Long-Term (Up To 24 Months) Outcome Of The Self-Expanding Nitinol Absolute Pro And The Balloon-Expandable Omnilink Elite Stent In TASC A & B And TASC C & D Iliac Lesions In 325 Patients

7:09 AM - 7:14 AM	Debate 3: Atherectomy Really Works Better Than POBA: Why Can’t Others Reproduce The Good Results?

7:15 AM - 7:20 AM	Debate 3: Atherectomy Really Does Not Work Very Well Even Though I Tried It

7:21 AM - 7:26 AM	Tips, Tricks, Techniques And Indications In Pedal Artery Access

7:27 AM - 7:32 AM	Can Diabetics With Neuropathy Have Their Symptoms Relieved By PTA: Do The Symptoms Recur With Restenosis?

7:33 AM - 7:39 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	14.1 - How Do We Know Atherectomy Works?

Web-Based Presentation	14.2 - Value Of Drug Eluting Balloons In Below The Knee Artery PTAs

Web-Based Presentation	14.3 - Tips And Tricks And New Techniques For Crossing Difficult SFA And Popliteal Occlusions: Is The Radiofrequency Wire Going To Help And How Can It Be Used?

Web-Based Presentation	14.4 - Use Of Standardized Percutaneous Techniques For SFA And Popliteal Artery TASC C And D Lesions Improves Outcomes

END OF SESSION 14

SESSION 15 SCHEDULE
Thursday SESSION 15: LOWER EXTREMITY HOT TOPICS II (5-MINUTE TALKS) Moderators: / TBD
x
7:40 AM - 7:45 AM	Why We Should Still Perform Pedal Bypasses In Some Patients

7:46 AM - 7:51 AM	Mid-Term Experience With Drug Eluting Balloons In SFA And Popliteal Arteries

7:52 AM - 7:57 AM	Debate 4: Stent Fractures In The SFA Do Matter: Let’s Look At The Data

7:58 AM - 8:03 AM	Debate 4: Stent Fractures In The SFA Do Not Really Matter

8:04 AM - 8:09 AM	How Does Paclitaxil On Stents And Balloons Work To Prevent Restenosis?

8:10 AM - 8:15 AM	Drug-Eluting Stents Below The Knee - Promises And Limitations: Update On The DESTINY And ACHILLES Trials Comparing DE To Bare Metal Stents

8:16 AM - 8:21 AM	What Is The eXtra Balloon And What Is Its Value In Endovascular Interventions?

8:22 AM - 8:27 AM	Debunking Another Surgical Myth: Stenting The CFA Is Always Bad And Must Be Avoided

8:28 AM - 8:33 AM	Value Of Drug Eluting (Cypher) Stents For Critical Limb Ischemia (CLI) After Failed PTA: Favorable Mid-Term Patency And Limb Salvage Results

8:33 AM - 8:40 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	15.1 - SFA And Crural Endovascular Revascularization: How Does One Decide Which Method To Use?

Web-Based Presentation	15.2 - Optimal Treatment For In-Stent Restenosis In The SFA; Below The Knee

Web-Based Presentation	15.3 - Does Cryoplasty Still Have A Role In The Treatment Of CLI?

END OF SESSION 15

SESSION 16 SCHEDULE
Thursday SESSION 16: LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS) Moderators: / TBD
x
8:41 AM - 8:46 AM	Results Of A Phase 3 Trial Of Novel Targeted Angiogenic Therapy With NV1FGF For Critical Limb Ischemia

8:47 AM - 8:52 AM	Debate 5: Long-Term Outcomes Of PTA For CLI: Outcomes Justify A PTA First Strategy: But In Whhich Patients?
	Presenters(s):Mark Conrad, MD
8:53 AM - 8:58 AM	Debate 5: Failed PTA/Stent Is Associated With Reduced Patency Of Subsequent Bypass: A Study From The VSGNE Database

8:59 AM - 9:04 AM	Retrograde Popliteal Access For SFA Recanalization: Indications, Technique And Results

9:05 AM - 9:10 AM	How To Do Popliteal Punctures And Procedures With The Patient In The Supine Position

9:11 AM - 9:16 AM	Patterns Of Recurrent Disease After SFA Interventions: How Should Such Recurrences Be Managed?

9:17 AM - 9:22 AM	Drug Eluting Balloons Improve Results Of PTA For Long Tibial Artery Lesions

9:23 AM - 9:28 AM	Durability Of PTAs Using Pedal Artery Approaches

9:29 AM - 9:34 AM	Patient Selection For Drug Eluting Stents In The Lower Extremity

9:35 AM - 9:40 AM	Below The Ankle Angioplasty: To Stent Or Not To Stent

9:41 AM - 9:47 AM	Panel Discussion
9:48 AM - 10:05 AM	Break / Visit Exhibits and Pavilions (2nd and 3rd Floors) CONCLUSION OF PROGRAMS A AND B. MEETING CONTINUES IN THE GRAND BALLROOM (3rd FLOOR) AS PLENARY SESSIONS.
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	16.1 - How To Avoid Use Of Reentry Devices When Crossing Total Occlusions

Web-Based Presentation	16.2 - Debate: Tibial Artery Lesions With CLI Do Better With Distal Open Bypasses

Web-Based Presentation	16.3 - Debate: Tibial Artery Lesions With CLI Do Better With Endovascular Treatment

Web-Based Presentation	16.4 - Long Bare Nitinol Stents For TASC C And D Fem-Pop Lesions (The DURABILIITY Trial): How Well Do They Do?

Web-Based Presentation	16.5 - Techniques And Advantages Of Treating Lower Extremity Disease With 4 French Systems: What Is Possible And What Is Not?

END OF SESSION 16

SESSION 17 SCHEDULE
Thursday SESSION 17: NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS AND MANAGEMENT OF CLI (5-MINUTE TALKS) Moderators: / TBD
x
10:05 AM - 10:10 AM	Performance Goals And Clinical Trial Designs To Permit Rapid Accurate Evaluation Of Safety And Efficacy Of CLI Treatment Devices

10:11 AM - 10:16 AM	Are We Making Progress In The Endovascular Treatment Of SFA Disease Or Will All Treatments Prove Equally Ineffective: Is The High Cost Worth The Price?

10:17 AM - 10:22 AM	Endo First vs. Open First For CLI: Is The BASIL Trial Applicable In 2010: Is It Still Helpful?

10:23 AM - 10:28 AM	Long-Term Outcomes Of Endovascular Infrainguinal Treatments: Are They A Viable Modality Or A Revenue Generator?

10:29 AM - 10:34 AM	Late Results (3-5 Years) After Endovascular Treatment Of Crural And Pedal Disease Causing CLI

10:35 AM - 10:40 AM	Endovascular Techniques For Limb Salvage In Diabetics With Crural And Pedal Disease – Including Pedal Loop Techniques

10:41 AM - 10:46 AM	Early And Mid-Term Results Of Transpedal Revascularization Procedures

10:47 AM - 10:52 AM	Tricks For Crossing Total Occlusions In Lower Extremity Arteries

10:53 AM - 10:59 AM	Panel Discussion
Moderator(s): TBD / TBD
11:00 AM - 11:05 AM	Results Of Randomized Controlled Trial (RCT) Comparing Drug Eluting Stent (Zilver PTX) With PTA And Bare Metal Stent For SFA And Popliteal Lesions

11:06 AM - 11:11 AM	Results Of RCT Comparing Paclitaxil Coated Balloons With Uncoated Balloons For PTA In The SFA And Proximal Popliteal Artery (PACURA I Trial)

11:12 AM - 11:17 AM	Tips And Tricks For Treating Lower Extremity Occlusions In The SFA, Popliteal And Tibial Arteries: Can They All Be Crossed And How?

11:18 AM - 11:23 AM	Treatment Of In-Stent Restenosis: Is There Anything That Works?

11:24 AM - 11:29 AM	An Overview Of Drug Eluting Balloons: So Many Companies: So Many Trials: Where Are We And Where Are We Going?

11:30 AM - 11:35 AM	Subintimal Recanalization Of Occluded Stents: The “Substent Technique”

11:36 AM - 11:41 AM	Value Of Stem Cells From Bone Marrow In Otherwise Untreatable Patients With CLI Facing Amputation: It Works
	Presenters(s):Ralf R. Kolvenbach, MD
11:42 AM - 11:47 AM	Heparin Bonded PTFE vs. Vein In Below-Knee Bypasses: The U.S. And European Experience

11:48 AM - 11:55 AM	Panel Discussion
11:55 AM - 1:00 PM	Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
Web-Based Presentation	17.1 - Comparison Of Endovascular-First vs. Surgical Revascularization-First For Limb Salvage In CLI: 5-Year Results Are Similar

Web-Based Presentation	17.2 - Role And Value Of The SUPERA Hi Radial Force Stent In Treating Calcified And Resistant SFA Lesions

Web-Based Presentation	17.3 - Value Of The ROTAREX System For In-Stent Restenosis At The Level Of The Iliac And Femoro-Popliteal Arteries

Web-Based Presentation	17.4 - What Is The Best Technique And Device For Mechanical Thrombectomy With Lower Extremity Arterial Lesions?

END OF SESSION 17

SESSION 18 SCHEDULE
Thursday SESSION 18: NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS) Moderators: / TBD
x
1:00 PM - 1:05 PM	Preserving Spinal Cord Vascularization With TEVAR: From Theory To Practice
	Presenters(s):Germano Melissano, MD
1:06 PM - 1:11 PM	Advantages Of The Cook PROFORM Thoracic Graft: Initial Clinical Experience
	Presenters(s):Timothy A. Resch, MD, PhD
1:12 PM - 1:17 PM	An Improved Thoracic Endograft For Tight Radius Aortic Arches: Advantages And Initial Clinical Experience

1:18 PM - 1:23 PM	New Developments In Thoracic Endografting And What Is On The Horizon

1:24 PM - 1:29 PM	Use Of Vascular Occluding Devices For Treating Reentry Tears In Patients With Persistent False Lumens After Endograft Treatment Of Type B Aortic Dissections
	Presenters(s):Wei Guo Fu, MD
1:30 PM - 1:35 PM	Debate 6: TAAAs Will All Be Treated With Endovascular Techniques

1:36 PM - 1:41 PM	Debate 6: That’s Nonsense: Some TAAAs Are And Will Always Best Be Treated By Open Repair
	Presenters(s):Hazim J. Safi, MD
1:42 PM - 1:47 PM	Panel Discussion
Moderator(s): TBD / TBD
1:47 PM - 1:52 PM	Debate 7: We Still Need A Randomized Controlled Trial (RCT) Of EVAR vs. Open Repair (OR) For Ruptured AAAs: The Ongoing (AJAX And ECAR) Trials Prove It

1:53 PM - 1:58 PM	Debate 7: RCTs Of EVAR And OR In Ruptured AAAs Are A Waste Of Time And Will Provide No Useful Information

1:59 PM - 2:04 PM	EVAR And OR For Ruptured AAA Produce Equal Mortality Rates: Other Factors Like Organization And Fluid Management Are More Important Than The Method Of Repair

2:05 PM - 2:10 PM	“EVAR Suitable Anatomy” Is A Favorable Factor For Open Repair Of Ruptured AAAs And Results In Better Outcomes: Maybe We Do Need A RCT But It Will Be Impossible To Carry Out

2:11 PM - 2:16 PM	Do Endoleaks After EVAR For RAAA Matter: How Should They Be Dealt With?

2:17 PM - 2:22 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	18.1 - Management Of Spinal Ischemia After Endovascular Repair Of TAAs Or TAAAs

Web-Based Presentation	18.2 - Prevention Of Spinal Cord Complications With TEVAR

Web-Based Presentation	18.3 - Resolving The Continuing Confusion Over Acute And Chronic Type B Aortic Dissections: Why Is The Distinction Crucial: An Endovascular Therapist’s Perspective

Web-Based Presentation	18.4 - TEVAR And Covering The Celiac Artery: Is It Safe Or Not?

END OF SESSION 18

SESSION 19 SCHEDULE
Thursday SESSION 19: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2010 (5-MINUTE TALKS) Moderators: / TBD
x
2:22 PM - 2:27 PM	Ten Top Tips For SAFE CAS: A Neuroradiologist’s Perspective

2:28 PM - 2:33 PM	Debate 8: CREST Has Restored CAS To Its Rightful Place As Best Treatment For Most Carotid Stenoses: An Interventionalist’s Perspective

2:34 PM - 2:39 PM	Debate 8: CREST May Be Helpful To Advocates Of CAS But It Is Not The Final Answer: When CEA, When CAS, When Best Medical Treatment (BMR_x): A Surgeon’s Perspective

2:40 PM - 2:45 PM	Debate 8: Subanalysis Of CREST Results Are Important: Were There Differences Between CAS And CEA In 1) Quality Of Life And 2) Cost Effectiveness; What Were The Severity And Disability From The MIs And The Cranial Nerve Injuries: A Neurologist’s Perspective

2:46 PM - 2:51 PM	The Woes Of CAS Are Not Fully Solved By CREST: When Is CAS Justified And When And Why Is It Not?

2:52 PM - 2:57 PM	Debate 9: We Do Not Need Any More CAS Trials After CREST And ICSS

2:58 PM - 3:03 PM	Debate 9: We Need Additional CAS Trials And Why

3:04 PM - 3:09 PM	Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For Treatment By CEA Or CAS In Most Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease

3:10 PM - 3:15 PM	Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For CEA Or CAS, In Some Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease

3:16 PM - 3:21 PM	Debate 10: Most Patients Undergoing Cardiac Surgery With Asymptomatic Carotid Disease Do Not Benefit From A Synchronous Or Staged Carotid Intervention

3:22 PM - 3:27 PM	Panel Discussion
Moderator(s): TBD / TBD
3:27 PM - 3:32 PM	Are There Neuropsychological Complications Of CAS Or CEA In The Absence Of Strokes?

3:33 PM - 3:38 PM	CAS vs. CEA: What Are The DWI MRA, Brain Damage Markers And Neuropsychological Consequences Of The Two Procedures In Asymptomatic Patients: An Update

3:39 PM - 3:44 PM	SPACE II: The Most Needed Comparison Of CAS, CEA And BMR_x For Asymptomatic Disease: Will It Provide Answers And When?

3:45 PM - 3:50 PM	When Is Cessation Or Reversal Of Brain Flow Protection A Must In CAS: What Are Its Disadvantages?

3:51 PM - 3:56 PM	National Database Update On CEA vs. CAS For Symptomatic And Asymptomatic Disease: Are CAS Results Improving?

3:57 PM - 4:02 PM	Serial Duplex Measurements Of Asymptomatic Carotid Lesions: Will They Help Identify Patients At Higher Risk For Stroke Who Will Benefit More From Invasive Treatment?

4:03 PM - 4:08 PM	How Can Asymptomatic Patients With Carotid Stenoses Be Identified To Be At High Stroke Risk In The Statin Era?

4:09 PM - 4:15 PM	Panel Discussion
4:15 PM - 4:25 PM	Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	19.1 - Toward Safer CAS: Tips And Tricks

Web-Based Presentation	19.2 - Does The CRYSTALLO Variable Cell Size Stent Lower Embolic Event Rates With CAS?

Web-Based Presentation	19.3 - Right Brachial Approach For Left Carotid Stenting With A Bovine Arch Anatomy

Web-Based Presentation	19.4 - Radial Approach For CAS: When, Why And How

Web-Based Presentation	19.5 - Flaws In The Empire Trial

Web-Based Presentation	19.6 - Will The TACIT Trial Ever Be Done?

END OF SESSION 19

SESSION 20 SCHEDULE
Thursday SESSION 20: NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS AND STENTS (5-MINUTE TALKS) Moderators: / TBD
x
4:25 PM - 4:30 PM	Update On The VIBRANT And VIPER Trials Showing The Value Of Endoluminal Bypass With The Viabahn Stent-Graft For Long SFA Disease

4:31 PM - 4:36 PM	RCT Of Viabahn Stent Grafts With Heparin Bonding vs. Bare Nitinol Stents In SFA Disease (The VIASTAR Trial): The Importance Of Edge Stenosis

4:37 PM - 4:42 PM	Endovascular Stent-Graft Treatment Of Popliteal Aneurysms With Only Duplex Guidance

4:43 PM - 4:48 PM	Are Stent-Grafts Better Than Bare Metal Stents For Treating Iliac Artery Occlusions (The COBEST Trial): What Is Their History And Limitations?

4:49 PM - 4:54 PM	Results With Second Generation Tissue Covered Stent-Grafts In The SFA And Popliteal Arteries

4:55 PM - 5:00 PM	What Is The Future For Biodegradable Stents And Biodegradable Polymers?

5:01 PM - 5:06 PM	Evolving Experience With Intracranial Stents: The Good And The Bad

5:07 PM - 5:12 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	20.1 - Debate: Open Surgery Is Still The Primary Approach For CLI

Web-Based Presentation	20.2 - Debate: Endovascular Treatments Should Be The Primary Approach For CLI: But Not For All Patients

Web-Based Presentation	20.3 - Are Failed Stent-Grafts In The SFA More Likely To Lead To CLI Than Failed Stents Or POBA?

Web-Based Presentation	20.4 - How Can Computer Modeling Help To Design Better Stents For Treating Fempop Occlusive Disease?

Web-Based Presentation	20.5 - Nitinol Stents Can Be Effective Across The Knee Joint

END OF SESSION 20

SESSION 21 SCHEDULE
Thursday SESSION 21: NEW CONCEPTS IN VASCULAR DISEASE AND ITS TREATMENT (4 AND 5-MINUTE TALKS) Moderators: / TBD
x
5:12 PM - 5:17 PM	Overview Of Established And New Antiplatelet Agents

5:18 PM - 5:23 PM	Treatment Of Multiple Sclerosis By Interventional Procedures To Reduce Venous Obstruction: When Is It Helpful And When Is It Not?

5:24 PM - 5:29 PM	Radiofrequency Periarterial Nerve Ablation From Within The Renal Artery To Treat Resistant Hypertension: Does It Work And How?

5:30 PM - 5:35 PM	Importance Of Previously Undetected Arrhythmias In High Risk Vascular Surgery Patients: The REVEAL Monitoring Device And How It Can Help Patient Management

5:36 PM - 5:41 PM	Difficult A-V Malformations Can Be Treated Effectively But It Is Hard: Tips And Tricks

5:42 PM - 5:47 PM	How To Start An A-V Malformation Program: Absolute Ethanol Can Be Dangerous But Helpful

5:48 PM - 5:52 PM	A Simple Way To Understand And Treat Vascular Malformations

5:53 PM - 5:58 PM	Treatment Of Angiodysplasia: Dirty Laundry And Lessons Learned

5:59 PM - 6:04 PM	Update On Stem Cell Therapy For CLI And Heart Failure: Will It Work?

6:05 PM - 6:10 PM	Update On The Status Of Gene Therapy For CLI: Will It Work?

6:11 PM - 6:16 PM	Panel Discussion
Web-Based Presentation	21.1 - Are Stem Cells Going To Become Widely Used For CLI?

END OF SESSION 21

SESSION 22 SCHEDULE
Thursday SESSION 22: PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS) Moderators: / TBD
x
6:16 PM - 6:21 PM	Systemic Inflammatory Response Syndrome (SIRS) And Its Importance In Vascular And Endovascular Procedures: What Is It And How Should It Be Diagnosed And Treated?

6:22 PM - 6:27 PM	What Is The Best Way To Minimize Brain Damage During CAS: Reversal Of Flow vs. Filter vs. No EPD: A Comparative Study Using DWI And Brain Enzymes As End Points

6:28 PM - 6:33 PM	Spiral Saphenous Vein Graft Reconstruction For Aortic Graft Infection: An Alternative For The Clagett-Nevelsteen Procedure Using Femoral (Deep) Vein Grafts

6:34 PM - 6:39 PM	Initial Clinical Experience With A New Low Profile AAA Stent-Graft Device (INCRAFT) From Cordis

6:40 PM - 6:45 PM	Debate 11: What Advances In Percutaneous Femoral Access Make It The Preferred Method For All Large Sheath Endovascular Procedures: A New Sheath To Minimize Blood Loss

6:46 PM - 6:51 PM	Debate 11: Tips And Tricks For Percutaneous Access For EVAR And TEVAR (Video)

6:52 PM - 6:57 PM	Debate 11: The Case Against “Preclose” Percutaneous Closure For Routine EVAR And TEVAR

6:58 PM - 7:03 PM	Is Fascial Closure Equal To Or Better Than Prostar Preclose Technique After Large Sheath Insertion: A Comparative Study

7:04 PM - 7:15 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	22.1 - Fascial Closure (Larzon Technique) After EVAR And TEVAR Works If Done Right And Is Cheaper: Experience In 100 Cases
	Presenters(s):Timothy A. Resch, MD, PhD
Web-Based Presentation	22.2 - Versatility Of The Fibrenet System For Brain Protection During CAS: Advantages And Limitations

Web-Based Presentation	22.3 - Tips And Tricks For Arterial Puncture To Avoid Complications

Web-Based Presentation	22.4 - Importance Of Fluvostatin In Vascular Surgery Patients: Optimal Dosing And Administration

Web-Based Presentation	22.5 - Bivalrudin For Anticoagulation: What Is Its Value For Peripheral Interventions?

END OF SESSION 22

Friday, November 19, 2010 Print Entire 2009 Program:
SESSION 23 SCHEDULE
Friday SESSION 23: NEW STENT TECHNOLOGY AND IMPROVED TECHNIQUES (5-MINUTE TALKS) Moderators: / TBD
x
6:40 AM - 6:45 AM	Component Bifurcated Iliac Graft For Preservation Of The Internal Iliac Artery During EVAR

6:46 AM - 6:51 AM	Thin Film Nitinol Membrane Covered Stents Can Prevent Plaque Protrusion And Decrease Emboli

6:52 AM - 6:59 AM	A PTFE Mesh Covered Stent To Prevent Plaque Prolapse And Embolization

7:00 AM - 7:05 AM	Endovascular Treatment Of Critical Hand Ischemia Due To Below-The-Elbow Arterial Disease: Are Drug Eluting Balloons Helpful?

7:06 AM - 7:11 AM	A New All Purpose Guidewire Of Variable Size And Properties To Avoid Time Consuming Exchanges: How Does It Work?

7:12 AM - 7:17 AM	Results From The U.S. Aorfix Trial

7:18 AM - 7:23 AM	A Two Wire Technique And Special Catheter To Facilitate And Simplify CAS

7:24 AM - 7:28 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	23.1 - New 3D Navigation Tools Using Merged CT And Fluoroscopic Images To Allow Wire And Catheter Navigation Without Contrast Injection

END OF SESSION 23

SESSION 24 SCHEDULE
Friday SESSION 24: JUXTARENAL, PARARENAL AND THORACOABDOMINAL AORTIC ANEURYSMS (TAAAS), CHIMNEY OR SNORKEL GRAFTS AND OTHER TECHNIQUES TO REVASCULARIZE VISCERAL ARTERIES (5-MINUTE TALKS) Moderators: / TBD
x
7:28 AM - 7:33 AM	Debate 12: Open Repair For Type IV TAAA Remains The Gold Standard For Most Good Risk Patients
	Presenters(s):Richard P. Cambria, MD
7:34 AM - 7:39 AM	Debate 12: Endovascular Repair With Branched Grafts Will Be Best For All Patients With Type IV TAAAs

7:40 AM - 7:45 AM	Results With An Off-The-Shelf Standardized Branched Endograft Device For TAAAs: When Can It Not Be Used?

7:46 AM - 7:51 AM	Do We Really Need Pre-Ordered And Off-The-Shelf Devices For Juxtarenal, Pararenal And TAAAs: How Are Surgeon-Modified Standard Endografts Improving

7:52 AM - 7:57 AM	Debate 13: New Techniques To Optimize Results With Chimney Grafts To Revascularize Aortic Branches

7:58 AM - 8:03 AM	Debate 13: Limitations Of Chimney Grafts: They Are Not As Good As Some Say

8:04 AM - 8:09 AM	Sandwich Technique For Improving Results With Chimney Grafts: Technique And Use For Hypogastric And Visceral Artery Branches
	Presenters(s):Armando C. Lobato, MD, PhD
8:10 AM - 8:15 AM	Multivessel “Terraced” Chimney Techniques For TAAAs: Will They Replace Branched Endografts

8:16 AM - 8:21 AM	Treatment Of Juxta And Pararenal AAAs With Bilateral Parallel (Chimney) Grafts, Covered Palmaz Stents And Standard Aortic Grafts: When Can These Be Used And When Can’t They Be?
	Presenters(s):Ralf R. Kolvenbach, MD
8:22 AM - 8:27 AM	Periscope Chimney Technique To Help With Urgent Treatment Of TAAAs: Up And Down 4-Vessel Chimney Grafts

8:28 AM - 8:33 AM	Technique For Retroperitoneal Approach To Abdominal (4-Vessel) Debranching For TAAAs: A Better Way

8:34 AM - 8:39 AM	New Classification System For TAAAs In The Branched Graft Era

8:40 AM - 8:45 AM	Fenestrated Grafts: When Can They Be Used And When Should They Not Be?

8:46 AM - 8:53 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	24.1 - Deployment Problems With Branched And Fenestrated Endografts: Rescue Procedures From "Nightmares"

Web-Based Presentation	24.2 - Fenestrated Grafts With Preloaded Wires: How Do They Help And Can Fenestrated And Branched Grafts Be Inserted With One Sided Access?

Web-Based Presentation	24.3 - A New Non-Sutured Telescoping Anastomotic Technique For Major Aortic Branch Revascularization With Minimal Dissection And Ischemia

Web-Based Presentation	24.4 - Lessons Learned And Technical Tips For Use Of Snorkel Or Chimney Grafts For Aortic Branch Revascularization

Web-Based Presentation	24.5 - Tips And Tricks With Use Of The Snorkel/Chimney Technique To Facilitate Aortic Debranching And TEVAR

END OF SESSION 24

SESSION 25 SCHEDULE
Friday SESSION 25: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA (5-MINUTE TALKS) Moderators: / TBD
x
8:53 AM - 8:58 AM	What Percentage Of CLI Patients Will Ultimately Need An Open Procedure (Bypass Or Thrombectomy)?

8:59 AM - 9:04 AM	When Endovascular Treatment And When Open Bypass For CLI: Do They Both Have A Role?

9:05 AM - 9:10 AM	Debate 14: Endovascular Treatment For CLI Is More Cost Effective Than Distal Bypass

9:11 AM - 9:16 AM	Debate 14: For Patients With CLI Endovascular-Only Treatment Is Equally Costly To Open-Only Treatment Even Though Open-Only Was Used On Patients With Worse Disease

9:17 AM - 9:22 AM	With CLI And Multilevel Disease, When And How Often Will Aortoiliac Recanalization Be Adequate Treatment?

9:23 AM - 9:28 AM	Endovascular Recanalization Of The Occluded Aorta By A Foolproof Method Using A Reentry Device And Stents To Save Collaterals: Midterm Follow-Up Is Good

9:29 AM - 9:34 AM	Is Buerger’s Disease Real Or Is It All Peripheral Arteriosclerosis And Should It All Be Treated As Such?

9:35 AM - 9:40 AM	Use Of A Surrogate Walker And Plantar Bellows To Treat CLI Not Suitable For Endo Or Open Treatment: How Does It Work?

9:41 AM - 9:46 AM	Panel Discussion
Moderator(s): TBD / TBD
9:46 AM - 9:51 AM	Pedal Bypass With Deep Vein Arterialization: A Therapeutic Option In Critical Ischemia With A Poor Distal Outflow Artery

9:52 AM - 9:57 AM	Debate 15: Progress In Bone Marrow Cell Treatment For CLI: It’s Not All Smoke And Mirrors And It May Save Limbs

9:58 AM - 10:03 AM	Debate 15: Hyperbaric Oxygen And Good Wound Care Do Just As Well As Bone Marrow Cells In CLI

10:04 AM - 10:09 AM	BK Pop And Crural Bypasses With Heparin-Bonded PTFE (Propaten): How Well Do They Work?

10:10 AM - 10:15 AM	RCT Comparing Propaten PTFE Stretch Grafts To Standard PTFE Stretch Grafts: A Multicenter Study Showing That Heparin Bonding Improves Patency

10:16 AM - 10:21 AM	4-Year Results With Viabahn Endoluminal Stent Grafts Do As Well As Standard Prosthetic (PTFE And Dacron) Fem-Pop Bypasses For SFA Occlusive Disease In A RCT

10:22 AM - 10:27 AM	High Platelet Count (> 400,000) Is A Predictor Of Early Failure Of Lower Extremity Bypasses: What Should Be Done About It?

10:28 AM - 10:33 AM	Atherosclerotic (Degenerative) Femoral Artery Aneurysms: What Are The Criteria For Repair?

10:34 AM - 10:40 AM	Panel Discussion
10:40 AM - 10:50 AM	Break / Visit Exhibits and Pavilions (2nd and 3rd Floors)
Web-Based Presentation	25.1 - What Is The Optimal Treatment For Mixed Arterial And Venous Ulcers?

END OF SESSION 25

SESSION 26 SCHEDULE
Friday SESSION 26: ADVANCES IN MEDICAL TREATMENT AND TREATMENT OF MEDICAL PROBLEMS (5-MINUTE TALKS) Moderators: / TBD
x
10:50 AM - 10:55 AM	Debate 16: Beta Blockade Was Not Beneficial To AAA Repair And Leg Bypass Patients: A Study From The VSGNE Database

10:56 AM - 11:01 AM	Debate 16: Beta Blockers Don’t Do Much But Statins Are Even Better Than We Realized In Vascular Surgery Patients: What Is The Proper Dosage?

11:02 AM - 11:07 AM	Debate 16: Beta Blockers Are Beneficial In Vascular Surgery Patients And Need Not Increase Stroke Risk: They Just Have To Be Used Properly: What Is Proper Usage?

11:08 AM - 11:13 AM	New Developments In Best Medical Treatment (BMR_x): Are There Ways To Raise HDL Or Lower Triglycerides: When Are They Indicated And Do They Help Prevent Atherosclerotic Events?

11:14 AM - 11:19 AM	Present Status And Future Possibilities With Drug Eluting Stents
	Presenters(s):Martin B. Leon, MD
11:20 AM - 11:25 AM	Aggressive Lipid Lowering Is Better Than Moderate Lipid Lowering In Stabilizing Carotid Plaques: What Dose Should We Give To Who, And How Does This Dose Change The Plaque?

11:26 AM - 11:31 AM	New Opportunities And Best Management With Antiplatelet Therapy For Prevention Of Coronary Stent Thrombosis In Patients Undergoing Vascular Procedures

11:32 AM - 11:37 AM	Should We Measure CRP Before Vascular Procedures: What Does A High CRP Mean And What Can Be Done About It?

11:38 AM - 11:43 AM	Cardiovascular Disease And Anti-Aging And Regenerative Medicines: A Revolution In Vascular Care

11:44 AM - 11:49 AM	How Low An LDL Level Should We Strive For In Our Vascular Disease Patients And Those Undergoing Procedures: Optimal Statin Dosing

11:50 AM - 11:58 AM	Panel Discussion
11:58 AM - 1:00 PM	Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 26

SESSION 27 SCHEDULE
Friday SESSION 27: SPECIAL SESSION ON RELATIONSHIPS BETWEEN INDUSTRY, PHYSICIANS, CME AND ADVAMED (7-MINUTE TALKS) Moderators: / TBD
x
12:03 PM - 12:10 PM	Is The Medical Inquisition Here To Stay: State And Federal Governments, ADVAMED And Some Universities Are Imposing Unfair Restrictions On Physicians And Industry Which Will Prevent Physician Education And Harm Patients: This Witch Hunt Must Stop

12:11 PM - 12:18 PM	Rules About CME Are Unreasonable And Part Of A Witch Hunt That Harms CME And Ultimately Will Harm Patients

12:19 PM - 12:26 PM	What Will Be Lost By Conflict Of Interest Mandates To Separate Practicing Physicians And Surgeons From Industry?

12:27 PM - 12:34 PM	What Will Happen To Large CME Meetings And What Can We Do About It?

12:35 PM - 12:42 PM	Redesigning The Relationship Between Physicians And Industry So That Everyone Wins

12:43 PM - 12:58 PM	Questions And Discussion
END OF SESSION 27

SESSION 28 SCHEDULE
Friday SESSION 28: MORE ON THORACIC AORTIC ANEURYSMS (TAAS) AND AAAS AND THEIR TREATMENT AND PREVENTION (5-MINUTE TALKS) Moderators: / Matt M. Thompson, MD
x
1:00 PM - 1:05 PM	Improved Grafts For TEVAR: The VALIANT And CAPTIVA Systems: Early Results

1:06 PM - 1:11 PM	New Findings From The INSTEAD Trial: Remodeling With And Without Endograft Treatment: What Is The Significance Of The Differing Results?
	Presenters(s):Christoph A. Nienaber, MD, PhD
1:12 PM - 1:17 PM	CT Follow-up After EVAR Is Bad For The Kidneys

1:18 PM - 1:23 PM	Preoperative Relative AAA Thrombus Burden Predicts Endoleak And Sac Enlargement After EVAR

1:24 PM - 1:29 PM	Bioenhanced Devices With Local Drug Delivery Have A Role In AAA Treatment

1:30 PM - 1:35 PM	New Technology For Extravascular Or Intravascular Stabilization Of AAAs: The VATRIX System To Influence The AAA Wall

1:36 PM - 1:41 PM	Debate 17: We Must Have Level I Evidence That EVAR Is Better Than Open Repair For Ruptured AAAs

1:42 PM - 1:47 PM	Debate 17: EVAR For Ruptured AAAs Is Better: Open Treatment If The Patient Has Favorable Anatomy Is Akin To Murder

1:48 PM - 1:53 PM	How Best To Treat Patients With An AAA And Iliac Occlusive Disease: Tips And Tricks

1:54 PM - 1:59 PM	Duplex Ultrasonography Done Early After EVAR Can Predict Which Type II Endoleaks Are Going To Persist And Lead To AAA Sac Enlargement

2:00 PM - 2:05 PM	How Often Does Embolization Of Type II Endoleaks Prevent Sac Expansion: What Can Be Done When It Fails?

2:06 PM - 2:12 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	28.1 - 1-Year Trial Results With The VALIANT Stent-Graft For Treatment Of Complicated Type B Aortic Dissections
	Presenters(s):Matt M. Thompson, MD
END OF SESSION 28

SESSION 29 SCHEDULE
Friday SESSION 29: PROGRESS IN VASCULAR IMAGING FOR INTERVENTIONALISTS (5-MINUTE TALKS) Moderators: / TBD
x
2:12 PM - 2:17 PM	Aneurysm Neck Dynamics As Seen By 4D MRA: How Will It Influence The Choice Of Endograft And EVAR Outcomes?

2:18 PM - 2:23 PM	CTA/PET Scanning And Its Value In Diagnosis And Treatment Of Vascular Disease

2:24 PM - 2:29 PM	Dynamic CT Fusion With Prior CTA: How Will It Improve Interventions And Decrease Dye Loads And X-ray Exposure: How Does It Work?

2:30 PM - 2:35 PM	Value Of 3D Rotational CTA To Facilitate Fenestrated/Branched Endograft Placement

2:36 PM - 2:41 PM	Dual Energy CT In Vascular Imaging: Advantages And Limitations

2:42 PM - 2:47 PM	Can CTA Evaluate The Circle Of Willis: How Can This Help In CEA And CAS?

2:48 PM - 2:53 PM	Improvements In TeraRecon 3D Imaging For EVAR And TEVAR: It Is Now Easier For Surgeons To Use

2:54 PM - 2:59 PM	Progress In The Value Of IVUS And Virtual Histology In Various Vascular Beds

3:00 PM - 3:05 PM	Pre And Post Procedural Imaging For Lower Extremity Arteriosclerosis: Which Is Best And How To Make Them Better With 3D Post Processing

3:06 PM - 3:11 PM	Panel Discussion and Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 29

SESSION 30 SCHEDULE
Friday SESSION 30: PROGRESS IN VENOUS DISEASE AND ITS TREATMENT (5-MINUTE TALKS) – PART I Moderators: / TBD
x
3:19 PM - 3:24 PM	RCT Comparison Of IVC Filters: Greenfield vs. TrapEase: Which Causes More Caval Thrombosis?

3:25 PM - 3:30 PM	Debate 18: The Greater Saphenous Vein Should Be Preserved When Treating Most Varicose Veins

3:31 PM - 3:36 PM	Debate 18: The Greater Saphenous Vein Should Almost Never Be Preserved When Treating Varicose Veins

3:37 PM - 3:42 PM	Complications Of Radiofrequency And Laser Endovenous Ablation

3:43 PM - 3:48 PM	Reduction Of Venous Ulcers By 50%: Is That Feasible In The U.S. In 10 Years? Report From American Venous Forum’s Expert Meeting In Hawaii November 2009

3:49 PM - 3:54 PM	Debate 19: Deep Venous Thrombectomy With AVF: It Still Has A Role In The Endovascular Era

3:55 PM - 4:00 PM	Debate 19: Catheter Directed Thrombolysis Is The Best Treatment For Most Patients With Ileofemoral DVT: It Decreases Postphlebitic Syndrome And Recurrent DVT

4:01 PM - 4:06 PM	Debate 19: Anticoagulation Is Best For Most DVT Patients: The Only Reason For The Endovascular Treatment Of DVT Is To Provide Business For Interventionalists

4:07 PM - 4:12 PM	Tips And Tricks For Performing Lytic Treatment For DVT: Technique Matters

4:13 PM - 4:18 PM	Panel Discussion
Moderator(s): TBD / TBD
4:19 PM - 4:24 PM	Treatment Of Pulmonary Emboli With Catheter Directed Ultrasound (EKOS) Thrombolysis: A Better Way

4:25 PM - 4:30 PM	Safety, Value And Advantages Of A New Ultrasound Technique (EKOS) For Thrombolysis In DVT

4:31 PM - 4:36 PM	Inflammatory Biomarkers That Allow A Blood Test Diagnosis Of DVT

4:37 PM - 4:42 PM	Hyperbaric Oxygen Therapy Is More Effective Clinically And In Terms Of Cost Than Compression Treatment For Refractory Venous Ulcers

4:43 PM - 4:48 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	30.1 - Further Experience With The ROTAREX Device In The Treatment Of Massive Pulmonary Emboli

Web-Based Presentation	30.2 - Discovery Of Venous Valves: Myth Or Reality?

END OF SESSION 30

SESSION 31 SCHEDULE
Friday SESSION 31: PROGRESS IN VENOUS DISEASE (5-MINUTE TALKS) – PART II Moderators: / TBD
x
4:48 PM - 4:53 PM	Advances In Venous Disease Research In 2010

4:54 PM - 4:59 PM	Complications After IVC Retrievable Filters Can Damage Adjacent Structures: How To Prevent Such Damage

5:00 PM - 5:05 PM	The NOVATE Bioconvertible IVC Filter: The Next Generation Device Where The Filter Converts To A Stent

5:06 PM - 5:11 PM	Debate 20: We Need Stricter Criteria For Use Of Caval Interruption Devices

5:12 PM - 5:17 PM	Debate 20: We Do Not Need Stricter Criteria For Use Of Caval Interruption Devices

5:18 PM - 5:23 PM	Indications And Technique For Treating Popliteal Venous Aneurysms: Why Are They Dangerous?

5:24 PM - 5:29 PM	Debate 21: Stents Are Usually Required In The Endovascular Treatment Of Chronic Venous Disease

5:30 PM - 5:35 PM	Debate 21: Stents Are Best Avoided In The Endovascular Treatment Of Chronic Venous Disease

5:36 PM - 5:41 PM	How To Deal With The Large Marginal Lateral Vein In Klippel Trenaunay Syndrome Patients: Excision, Laser, Foam Or Retreat?

5:42 PM - 5:47 PM	Best Practice Guidelines For Managing Venous Ulcers: What Is Best And What Is Really Being Done In The US And Europe?

5:48 PM - 5:53 PM	Conservative Treatment With Compression And Antiplatelet Agents Is As Effective As Anticoagulation With Isolated Gastrocnemius Or Soleal DVT

5:54 PM - 5:59 PM	Aggressive Treatment Of Chronic DVT With Thrombolysis And Mechanical Clot Removal: When Is It Indicated And Does It Work?

6:00 PM - 6:05 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	31.1 - Endovascular And Combined Endovascular-Surgical Treatment For DVT

Web-Based Presentation	31.2 - Why Is Screening For Venous Disease Important: 5-Year Report From The National Venous Screening Program Of The AVF

Web-Based Presentation	31.3 - The CHIVA Procedure For Leaving The Greater Saphenous Vein Intact When Treating Varicose Veins: Why Does It Work?

Web-Based Presentation	31.4 - Endovascular Treatment Of Varicocele And Pelvic Congestion Syndrome: Technique And Results

END OF SESSION 31

Saturday, November 20, 2010 Print Entire 2009 Program:
SESSION 32 SCHEDULE
Saturday SESSION 32: NEW DEVELOPMENTS IN ANEURYSMS AND THEIR TREATMENT: EVAR, THE TRIALS, LAPAROSCOPIC METHODS (5-MINUTE TALKS) Moderators: / TBD
x
6:40 AM - 6:45 AM	Anaconda Endograft For Juxtarenal AAAs: An “Off-the-Shelf” Solution To The Short (3-10 mm) Infrarenal Neck: Technical Details With The Possible Use Of Supplementary Stents

6:46 AM - 6:51 AM	Modifiable And Unmodifiable Predictors Of Preoperative Mortality And Morbidity In Open AAA Repair

6:52 AM - 6:57 AM	Best Strategy For Treating Huge AAAs > 15 cm In Diameter: Open vs. Endo

6:58 AM - 7:03 AM	Renal Artery Revascularization By Totally Laparoscopic Techniques

7:04 AM - 7:09 AM	Debate 22: Rupture After EVAR Is More Benign Than The Usual Ruptured AAA

7:10 AM - 7:15 AM	Debate 22: Rupture After EVAR Is Not More Benign Than The Usual Ruptured AAA

7:16 AM - 7:21 AM	New From The EVAR Trial: Mortality Catch-Up After EVAR: What Is It Due To?

7:22 AM - 7:27 AM	How To Do Open AAA Repair Of Large AAAs Through A Tiny Incision

7:28 AM - 7:33 AM	Panel Discussion
Moderator(s): TBD / TBD
7:33 AM - 7:38 AM	Debate 23: Short-Term And Long-Term Outcomes After EVAR And Open Repair Of RAAAs From The Medicare Database: They Are Equally Bad For Open And Endo
	Presenters(s):Mark Conrad, MD
7:39 AM - 7:44 AM	Debate 23: Single Center Outcomes Of EVAR And Open Repair For Ruptured AAAs: The Short-Term Survival Benefit Of EVAR Is Sustained Long-Term

7:45 AM - 7:50 AM	More That Is New From The EVAR Trials: Rupture After EVAR Is More Common Than After Open Repair Of AAAs Shown In The EVAR UK Trials I And II

7:51 AM - 7:56 AM	What Is New From The DREAM Trial: Are There Long-Term Survival Benefits Of EVAR?

7:57 AM - 8:02 AM	5-Year Results Of The French ACE Trial Comparing EVAR With Open Repair In Standard Risk Patients

8:03 AM - 8:08 AM	What Is New From The OVER VA Trial Of EVAR vs. Open Repair For Standard Risk AAAs?
	Presenters(s):Frank A. Lederle, MD
8:09 AM - 8:14 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	32.1 - Innovation In AAA Diagnosis And Treatment: What Does The Future Hold?

Web-Based Presentation	32.2 - Does AAA Diameter Influence Long-Term Patient Survival After Elective EVAR And Open Repair?

Web-Based Presentation	32.3 - Why Is The Mortality For Elective And Ruptured AAA Repair (Open And Endo) So Much Higher In Women? Can It Be Fixed?

Web-Based Presentation	32.4 - Tips And Tricks For Open Conversion After Failed EVAR

Web-Based Presentation	32.5 - Are Outcomes For Hemodynamically Stable Ruptured AAA Patients Different From Those Who Are Unstable?

END OF SESSION 32

SESSION 33 SCHEDULE
Saturday SESSION 33: NEW DEVELOPMENTS IN THE TREATMENT OF THE AORTA AND ITS BRANCHES (5-MINUTE TALKS) Moderators: / TBD
x
8:14 AM - 8:19 AM	A Telescoping Sutureless Aortic Anastomosis Using An Endograft Connector For Aortoiliac Occlusive Disease In Which The Aorta Cannot Be Clamped Or Sewn Due To Calcification Or Scarring: A New Hybrid Technique

8:20 AM - 8:25 AM	Debate 24: Open Surgery Is Never Needed For Aortoiliac Occlusive Disease
	Presenters(s):Edward B. Diethrich, MD
8:26 AM - 8:31 AM	Debate 24: Aortoiliac Stents Are Not All They Are Cracked Up To Be: Open Surgery Is Sometimes Better

8:32 AM - 8:37 AM	Aortoiliac Occlusions Should First Be Treated Endovascularly: Do Any Require Open Surgery?

8:38 AM - 8:43 AM	Contemporary Management Of Splenic Artery Aneurysms: Indications For Endo And Open Treatment

8:44 AM - 8:49 AM	A New Concept For A Branched Endograft For Left Subclavian Revascularization With TEVAR

8:50 AM - 8:55 AM	Minimally Invasive Treatment Of Visceral Aneurysms: When Can It Work, When Can It Not?

8:56 AM - 9:01 AM	Visceral Aneurysms: Role Of Open And Endovascular Treatments

9:02 AM - 9:07 AM	Panel Discussion
Moderator(s): TBD / TBD
9:08 AM - 9:13 AM	Current Status Of Renal Artery Stenting: It Is Not Dead But Why Is It So Hard To Prove Its Value?

9:14 AM - 9:19 AM	Improved Stents, Balloons And Embolic Protection Devices (EPDs) For Renal Artery Stenting

9:20 AM - 9:25 AM	Errors In Selection Criteria For Renal Artery PTA And Stenting: There Is Still A Role For Open Repair

9:26 AM - 9:31 AM	Debate 25: There Is No Need For EPDs In Renal Artery Stenting If One Uses Optimal Techniques

9:32 AM - 9:37 AM	Debate 25: EPDs Should Be Used In Renal Artery Stenting Whenever Possible

9:38 AM - 9:43 AM	For Chronic Visceral Ischemia When Is Endovascular Treatment Indicated And When Is Open Surgical Repair The Best Treatment?

9:44 AM - 9:55 AM	Panel Discussion And Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	33.1 - How Should Renal Artery In Stent Restenosis And Stent Fractures Be Best Treated?

Web-Based Presentation	33.2 - Renal Artery Stents Perform Poorly: We Need Covered Or Otherwise Modified Stents

Web-Based Presentation	33.3 - Should We Forget About Aortoiliac Endarterectomy?

Web-Based Presentation	33.4 - Indications And Value Of Hypogastric Artery Stenting

Web-Based Presentation	33.5 - Flaws In The ASTRAL And CORAL Trials: Renal Artery Stenting Still Has A Role

Web-Based Presentation	33.6 - Upper Extremity Access For Renal Artery Stenting: Radial, Brachial And Axillary Access: How To Do Them Safely And Pitfalls To Avoid

Web-Based Presentation	33.7 - Tips And Tricks For Subintimal Angioplasty For Iliac Occlusions: Open Operation May Be Obsolete

Web-Based Presentation	33.8 - Iliac Artery Entrapment In Cyclists: Diagnosis And Treatment

Web-Based Presentation	33.9 - Importance Of Fractures In Renal Artery Stenting: How To Prevent Them

END OF SESSION 33

SESSION 34 SCHEDULE
Saturday SESSION 34: THE FUTURE: ISSUES REGARDING HEALTH CARE CONCEPTS (5-MINUTE TALKS) Moderators: / TBD
x
9:55 AM - 10:00 AM	Debate 26: Should Major Vascular Procedures Be Centralized: Yes – It Is Best For All Concerned
	Presenters(s):Matt M. Thompson, MD
10:01 AM - 10:06 AM	Debate 26: Should Major Vascular Procedures Be Centralized: Hell No – It Can Never Be Done

10:07 AM - 10:12 AM	Impact Of Health Care Reform On Vascular Surgery And Its Practice

10:13 AM - 10:18 AM	What Is Health Care Reform All About: Will It Hurt Vascular Surgery, Health Care In General And Our Country: How?

10:19 AM - 10:24 AM	Surgeon And Physician Interaction With Device And Pharmaceutical Companies: What Is Going On In Massachusetts And Is This The Canary In The Coal Mine Before The Explosion: What Can Be Done About It?

10:25 AM - 10:30 AM	A View From Industry: The Negative Impact And Unintended Consequences Of Health Care Reform: What Can Be Done About It?

10:31 AM - 10:36 AM	Changes In Coding And Reimbursement For Endovascular Lower Extremity Intervention In 2011

10:36 AM - 10:44 AM	Panel Discussion
END OF SESSION 34

SESSION 35 SCHEDULE
Saturday SESSION 35: A TRIBUTE TO OUR MILITARY (5-MINUTE TALKS) Moderators: / TBD
x
10:44 AM - 10:49 AM	Task Force Leatherneck: A Surgeon’s Perspective From Afghanistan

10:50 AM - 10:55 AM	Vascular Injury Rates In The Iraq And Afghanistan Wars: How Are They Different From The Past?

10:56 AM - 11:01 AM	Some Historical Vignettes In Vascular Surgery: Who Did What First?

11:02 AM - 11:07 AM	Panel Discussion
END OF SESSION 35

SESSION 36 SCHEDULE
Saturday SESSION 36: COST, TRAINING, AND BUSINESS ISSUES (5-MINUTE TALKS) Moderators: / TBD
x
11:08 AM - 11:13 AM	How Can Device And Supply Costs For Endovascular Procedures Be Minimized By A Computerized Management System With Vascular Surgeon Input?

11:14 AM - 11:19 AM	Simplified Billing And Coding Software To Facilitate Recordkeeping And Billing And Save Time And Energy In A Vascular Practice

11:20 AM - 11:25 AM	Do Popular Media And Internet Hospital Quality Ratings Identify Hospitals With Better Cardiovascular Surgery Outcomes?

11:26 AM - 11:31 AM	FDA Perspective On Current Challenges Facing Clinical Evaluation Of Peripheral Vascular Devices

11:32 AM - 11:37 AM	Robotics And Endovascular Navigation: Progress In And Importance For In Situ Fenestration And Other Complex Procedures

11:38 AM - 11:43 AM	3D Endovascular Mechanical Simulator System (The Pontressina System): A Valuable New Approach To Improve Simulator Training

11:44 AM - 11:49 AM	How To Set Up A Comprehensive Diabetes Program

11:50 AM - 11:55 AM	Cost Impact Of Statins In AAA Repair: They Make A Difference

11:55 AM - 12:00 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	36.1 - How Can Endovascular Procedures Be Done Effectively And In A Freestanding Outpatient Facility To Keep It In The Black?

END OF SESSION 36

SESSION 37 SCHEDULE
Saturday SESSION 37: LUNCHEON LECTURES: NEW AND IMPROVED ENDOGRAFTS, TECHNIQUES AND DEVICES (5-MINUTE TALKS) Moderators: / TBD
x
12:00 PM - 12:05 PM	The Improved TRIVASCULAR Graft: History, Improvements, Advantages And Recent And Long-Term Clinical Experience

12:06 PM - 12:11 PM	The NELLIX EVAR Endoprosthesis For Filling The AAA Sac With Polymer Filled Endobags While Maintaining Flow Through Stents: Technique, Early Results And Advantages

12:12 PM - 12:17 PM	Contemporary 1-Year EVAR Outcomes From The U.S. IDE Trial And ENGAGE Global Registry Of The ENDURANT AAA Endograft Device

12:18 PM - 12:23 PM	Update On The US RELAY Trial For TEVAR

12:24 PM - 12:29 PM	Multicenter Clinical Experience With A Novel Repositionable AAA Endograft From W.L. Gore & Associates

12:30 PM - 12:35 PM	Advantages Of The Improved COOK TX2 Device For TEVAR

12:36 PM - 12:41 PM	Advantages And Limitations Of The ANACONDA AAA Endograft

12:42 PM - 12:47 PM	Update On The APTUS Devices And Trials

12:48 PM - 12:53 PM	Update On The Aorfix AAA Graft For Angulated Necks And Severe Iliac Angulation: The European 8-Year Results

12:54 PM - 12:59 PM	Off-The-Shelf Fenestrated Device From Endologix For Treatment Of Pararenal And Juxtarenal AAAs: Initial Clinical Experience

12:59 PM - 1:04 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	37.1 - Advantages Of The Cook ZENITH LP Device For AAAs

Web-Based Presentation	37.2 - Update On The US ANACONDA Trial

Web-Based Presentation	37.3 - 3-Year Results With The Cook RENU Proximal Cuff Device For Treating Failed/Migrated Endografts Without Or With Type I Leaks

Web-Based Presentation	37.4. - European Experience With The RELAY Endograft In 304 TEVAR Cases

Web-Based Presentation	37.5 - Significant Reduction Of Aneurysm Volumes After EVAR With Excluder Low Permeability Graft: Comparison With Original Excluder After 4 Years Of Follow-Up

Web-Based Presentation	37.6 - One-Year Clinical Experience With The TriVascular OvationT Abdominal Stent Graft

END OF SESSION 37

SESSION 38 SCHEDULE
Saturday SESSION 38: ETHICS, STANDARDS, CONCEPTS, MALPRACTICE (5-MINUTE TALKS) Moderators: / TBD
x
1:05 PM - 1:09 PM	Off-Label Device Use: An FDA Division of Cardiovascular Devices Perspective

1:10 PM - 1:15 PM	Are There Alternate Pathways To FDA Approval Of Vascular Devices That We Can Use?

1:16 PM - 1:21 PM	Off-Label Use Of A Drug Or Device Or Use Of A New Device With Little Experience Can Lead To Malpractice Liability

1:22 PM - 1:27 PM	How To Be A Good Expert Witness

1:28 PM - 1:33 PM	Surgical Infomercials The Ethical Price Of Stardom: But Are They Right?

1:34 PM - 1:39 PM	The Social (Public) Media And Their Impact On Patient Care, Patient Recruitment And Patient-Physician Interaction
	Presenters(s):Grayson H. Wheatley, MD
1:40 PM - 1:45 PM	Does Stent Placement Have A Learning Curve: What Mistakes Do We As Operators Make And How Can They Be Avoided?

1:46 PM - 1:51 PM	Is Red Wine Really Helpful For Vascular Disease Patients: Why And What Dose Is Best?

1:52 PM - 1:57 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	38.1 - What Motivates Us As Vascular Specialists To Perform Procedures Other Than Patient Benefit?

Web-Based Presentation	38.2 - Are Some Centers With Good Mortality And Morbidity Results For AAA Repair, Etc., Guilty Of Turning Down Bad Patients: Does This Render Quality Evaluations Difficult?
	Presenters(s):Matt M. Thompson, MD
Web-Based Presentation	38.3 - Assessing Quality And Risk In Our Health Care System: The Good, The Bad And The Ugly: Is PFP Going To Be Fair And Beneficial Or Bad?

END OF SESSION 38

SESSION 39 SCHEDULE
Saturday SESSION 39: VASCULAR DISEASE NATURAL HISTORY, MEDICAL TREATMENT, PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS) Moderators: / TBD
x
1:58 PM - 2:03 PM	Can Medication Stabilize Or Reverse Vascular Disease: With Lipid Lowering How Low Should You Go?

2:04 PM - 2:09 PM	RHEOS Trial Update: Carotid Sinus Stimulation For Treatment Of Drug Resistant Hypertension: Does It Work?

2:10 PM - 2:15 PM	Influence Of ACE Inhibitors And Statins On AAA Growth And Rupture Risk: Do They Make A Difference And Why?

2:16 PM - 2:21 PM	Are ACE Inhibitors Of Value In Patients With Thoracic Aortic Aneurysms?

2:22 PM - 2:27 PM	Is The Cervical Approach For CAS With Flow Reversal Safer For The Brain Than Other CAS Approaches: Based On DWI MRI

2:28 PM - 2:33 PM	ONYX As An Adjunct In Treating Type I And Type II Endoleaks, Ruptured AAAs And Arterial Injuries: An Update

2:34 PM - 2:39 PM	New Developments In Statin Treatment Of Importance To Vascular Specialists And Their Patients: Which Statin; What Dosage?

2:40 PM - 2:45 PM	Endovascular Solutions To Aortoiliac Complications From Spine Surgery

2:46 PM - 2:51 PM	Drug Eluting Stents Are Great For Coronary Artery Disease Patients But Trouble For Vascular Surgeons: How To Get Them Through Surgery If They Have A Drug Eluting Stent

2:52 PM - 2:57 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS AND SLIDES THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	39.1 - Can Hybrid Open Chest Procedures Be Done Safely In A Modified Angio Suite?

Web-Based Presentation	39.2 - Vascular Surgeons Must Lead The Efforts For Their Patients To Get Proper Statin Treatment

Web-Based Presentation	39.3 - What Is The Role Of A Cervical Approach For CAS: How To Do It Safely?

Web-Based Presentation	39.4 - Endovascular Rescue Of Inadvertent Arterial Sheath Placement During Central Venous Catheterization: How To Recognize And Treat
	Presenters(s):Tilo Kölbel, MD, PhD
Web-Based Presentation	39.5 - Effect Of Statins On Early And Late Results Of CAS

Web-Based Presentation	39.6 - How To Solve The Problem Of Catching Or Snagging Wires During EVAR

END OF SESSION 39

SESSION 40 SCHEDULE
Saturday SESSION 40: UPDATES, NEW TECHNIQUES AND CONCEPTS (5-MINUTE TALKS) Moderators: / TBD
x
2:57 PM - 3:02 PM	Have Endovascular Treatments Altered The Management And Outcomes Of Acute Mesenteric Ischemia?

3:03 PM - 3:08 PM	Transvenous Transcaval Approach To AAA Sacs After EVAR To Treat Type II Endoleaks

3:09 PM - 3:14 PM	What Happens To The Femoral Artery With Manual Compression Hemostasis After Endovascular Procedures; Is It Totally Benign?

3:15 PM - 3:20 PM	Unusual Uses Of The ANACONDA Endograft And Its Components In Special Circumstances

3:21 PM - 3:26 PM	Use Of Covered Palmaz Stent (VI-Maquet) For Solving Difficult Neck Problems With EVAR

3:27 PM - 3:32 PM	Use Of Covered And Uncovered Palmaz Stents To Resolve Difficult Neck Problems With EVAR: When Is A Covered Stent Needed?

3:33 PM - 3:38 PM	Femoro-femoral Stabilizing Second Wire For Complex Hypogastric Artery Embolizations: Advantages And Technique

3:39 PM - 3:44 AM	What To Do During CAS With Flow Reversal If It Is Not Tolerated – Especially With Contralateral ICA Occlusion: How Can The Procedure Be Completed Safely With Embolic Protection?

3:45 PM - 3:50 PM	Panel Discussion
Moderator(s): TBD / TBD
3:50 PM - 3:55 PM	Debate 27: Suprarenal Fixation Is Best For Angled Necks
	Presenters(s):Bjõrn Sonesson, MD, PhD /
3:56 PM - 4:01 PM	Debate 27: Suprarenal Fixation Is Not Best For Angled Necks

4:02 PM - 4:07 PM	Femoral Endarterectomy And Iliac Stent-Grafting vs. Aortobifemoral Bypass: When Should The Former Replace The Latter?

4:08 PM - 4:13 PM	New Developments With The CARDIOMEMS Pressure Monitoring Device: When Is Its Use Beyond A Research Tool Justified?

4:14 PM - 4:19 PM	Coiling Techniques To Treat Endoleaks After EVAR: Tips And Tricks To Make Them Work

4:20 PM - 4:25 PM	The Truth About EVAR Surveillance From The European Survey Analysis: Is It Really A Good Thing?

4:26 PM - 4:31 PM	Duplex Ultrasound To Guide Treatment Of Popliteal Entrapment

4:32 PM - 4:37 PM	Clinical Importance Of Vein Graft Arterialization: How Good Is It; How Bad Can It Be?

4:38 PM - 4:43 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	40.1 - Use Of Covered Palmaz Stent (VI-Maquet) For Solving Difficult Neck Problems

Web-Based Presentation	40.2 - The European View Of CAS vs. CEA In Light Of All The Trials

Web-Based Presentation	40.3 - What Is The Best Technique For Measuring Intra-abdominal Pressure (IAP) And What Is The Relationship Between IAP And Colonic Perfusion?

Web-Based Presentation	40.4 - Is EVAR Indicated For Aortoduodenal Fistulas?

Web-Based Presentation	40.5 - AUI vs. Bifurcated Endografts For Treating Ruptured AAAs: Which Is Best?

END OF SESSION 40

SESSION 41 SCHEDULE
Saturday SESSION 41: MORE UPDATES AND NEW TECHNOLOGY (5-MINUTE TALKS) Moderators: / TBD
x
4:44 PM - 4:49 PM	Improved Technique For Treating Vascular Graft Infection With An Endograft, Debridement And A VAC Dressing

4:50 PM - 4:55 PM	When Is Intervention Indicated For Restenosis After An Endovascular Treatment?

4:56 PM - 5:01 PM	Do Outcomes Of Lower Extremity Revascularizations Differ In Men And Women?

5:02 PM - 5:07 PM	After EVAR When Is “Fix It And Forget It”, i.e. No Surveillance An Acceptable Strategy?

5:08 PM - 5:13 PM	Correlates Of AAA Thrombus Thickness And Location With Endoleak After EVAR

5:14 PM - 5:19 PM	Triple Fenestrated Endografts In The Treatment Of Juxtarenal AAAs: Advantages And Limitations

5:20 PM - 5:25 PM	Through-The-Knee Amputation From A Posterior Approach: A Better Alternative Than Above-Knee Amputation

5:26 PM - 5:30 PM	Panel Discussion
Moderator(s): TBD / TBD
5:30 PM - 5:35 PM	Tips And Tricks For Visceral Artery Stenting

5:36 PM - 5:41 PM	Fast Track Concept Can Make Open Aortic Surgery Comparable To Endovascular And Laparoscopic Aortic Surgery

5:42 PM - 5:47 PM	Sphingosine-1-Phosphate (S-1-P) And VEGF Offer Promise For Effective Angiogenesis In CLI
	Presenters(s):Renan Uflacker, MD
5:48 PM - 5:53 PM	Hostile Neck Anatomy Is Less Of A Contraindication To EVAR With Newer Endografts Than It Was: What Are The New Limits For Acceptable Neck Angulation?

5:54 PM - 5:59 PM	Endovascular Repair Of Penetrating Atherosclerotic Ulcers In The Infrarenal Aorta And Iliac Arteries: When And How Should They Be Treated?

6:00 PM - 6:05 PM	Remote SFA Endarterectomy With The Moll Ring Cutter: Technique And Results

6:06 PM - 6:11 PM	Experience With The Use Of The Multilayer Stent For The Treatment Of Peripheral And Visceral Aneurysms

6:12 PM - 6:17 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	41.1 - CO₂ Angiography Is Simple And Safe: How To Do It Effectively: Techniques And Precautions

Web-Based Presentation	41.2 - Bailout Options For Overstented Vital Aortic Branches

Web-Based Presentation	41.3 - Molecular Mechanisms Of AAA Formation: An Update And Will There Ever Be Effective Medical Treatment?

Web-Based Presentation	41.4 - How To Set Up A Program Of Independent Neurological Evaluation For CAS Trials

Web-Based Presentation	41.5 - Antiplatelet Treatment For Secondary Risk Prevention In Vascular Patients: Which Drug, What Dose, How Long?

END OF SESSION 41

Sunday, November 21, 2010 Print Entire 2009 Program:
SESSION 42 SCHEDULE
Sunday SESSION 42: NEW DEVELOPMENTS, CONCEPTS AND TECHNIQUES FOR EVALUATING CAROTID PLAQUES (5-MINUTE TALKS) Moderators: / TBD
x
6:45 AM - 6:50 AM	How To Make Ultrasound (Duplex) A Useful Surveillance Tool And Decrease The Number Of CTs After EVAR: Can Duplex Velocity Differences In Graft Limbs Indicate An Endoleak?

6:51 AM - 6:56 AM	Immune Mediated Coagulopathy: A Complication Of Bovine Thrombin: How Can It Be Recognized, Prevented And Treated?

6:57 AM - 7:02 AM	Inadvertent Arterial Injury Secondary To Treatment Of Varicose Veins And Venous Insufficiency By Surgery And Foam: Diagnosis And Treatment

7:03 AM - 7:08 AM	Practical Measures For Radiation Protection During Endovascular Procedures

7:09 AM - 7:14 AM	How To Manage Infected Carotid Patches

7:15 AM - 7:20 AM	Computerized Models Of Displacement Forces Can Be Helpful In Predicting Migration Of Endografts After EVAR And Can Help In Graft Selection

7:21 AM - 7:26 AM	Standardized And Semiautomatic Noninvasive Evaluation Of Carotid Plaque Activity For Predicting Stroke Risk In Asymptomatic Patients: The Activity Index

7:27 AM - 7:32 AM	Relationship Between Atherosclerotic Plaque Composition By IVUS And Cerebral Embolization

7:33 AM - 7:38 AM	New Techniques (PET And MSOT [Multispectral Optacoustic Tomography] Scanning) For Imaging Carotid Plaques To Determine Their Vulnerability To Have Strokes: Do They Work In Asymptomatic Patients?

7:39 AM - 7:44 AM	Spinning Of CREST

7:45 AM - 7:50 AM	Contrast Enhanced Ultrasound To Identify Asymptomatic Carotid Plaques At Risk For Causing A Stroke

7:51 AM - 7:56 AM	Carotid Plaque Composition Relates To Symptomatic Status Of Patients And The Incidence Of Restenosis: How Should Plaque Composition Influence Treatment?

7:57 AM - 8:02 AM	Can Asymptomatic Patients With Carotid Plaques Who Are At High Risk For Stroke Be Identified Noninvasively: The ACSRS Study In > 1,000 Patients

8:03 AM - 8:08 AM	Novel Technique For Assessing Plaque Risk Noninvasively In Patients With Asymptomatic Carotid Stenoses

8:09 AM - 8:13 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	42.1 - Predictors Of Mortality With Open And Endovascular Treatment Of Ruptured AAAs

Web-Based Presentation	42.2 - New Concepts In Effort Thrombosis And Neurogenic Thoracic Outlet Syndrome And How They Are Best Treated

Web-Based Presentation	42.3 - C. Difficile Colitis Is Associated With Increased Mortality In All Vascular Surgery Patients

Web-Based Presentation	42.4 - Multilayer Stent For The Treatment Of Popliteal Aneurysms

Web-Based Presentation	42.5 - CAS vs. CEA: Which Is Best For The Surgeon Who Can Do Both Well?

Web-Based Presentation	42.6 - CEA Or CAS Should Be Performed In The Acute Period After A TIA Or Minor Stroke Without Increasing Procedural Risk: How Can This Be Done Safely?

END OF SESSION 42

SESSION 43 SCHEDULE
Sunday SESSION 43: MORE ABOUT ABDOMINAL AND THORACIC ANEURYSMS (5-MINUTE TALKS) Moderators: / TBD
x
8:18 AM - 8:23 AM	Use Of A Large Diameter, Low Profile (8 Fr Delivery System) Balloon Expandable Covered Stent (ADVANTA V12) For The Treatment Of Aortic Coarctation

8:24 AM - 8:29 AM	New Findings And Interpretations From The CAESAR Small AAA Trial

8:30 AM - 8:35 AM	New Findings And Interpretations From The PIVOTAL Small AAA Trial

8:36 AM - 8:41 AM	The Strange Relationship Between Diabetes And AAAs
	Presenters(s):Frank A. Lederle, MD
8:42 AM - 8:47 AM	10 Top Technical Tips For Performing EVAR With Challenging Anatomy

8:48 AM - 8:53 AM	Predictors Of Poor Outcomes With EVAR Using NSQIP Database: How Can It Help Us Make Better Clinical Decisions?

8:54 AM - 8:59 AM	Impact Of Obesity On Treatment Outcomes Of AAA Treatment With EVAR And Open Repair: Should Obesity Influence Choice Of Treatment Methods?

9:00 AM - 9:05 AM	Panel Discussion
Moderator(s): TBD / TBD
9:05 AM - 9:10 AM	Lessons Learned From Late Retreatment After EVAR Failure

9:11 AM - 9:16 AM	How Can Theoretical Mathematical And Bench Top Models Of Acute Aortic Dissection Be Helpful?

9:17 AM - 9:22 AM	When Can The Celiac Axis Be Covered Safely During TEVAR: Can There Be Adverse Outcomes And How Can They Be Predicted?

9:23 AM - 9:28 AM	Debate 28: When The Left Subclavian Artery Is Covered In A TEVAR Procedure, It Must Be Revascularized: The SVS Guidelines Say So

9:29 AM - 9:34 AM	Debate 28: When The Left Subclavian Artery Is Covered In A TEVAR Procedure, It Should Only Be Revascularized Selectively
	Presenters(s):Timothy A. Resch, MD, PhD
9:35 AM - 9:40 AM	Significance Of Air Bubbles In An Aneurysm Sac After TEVAR Or EVAR: How Long Postop Can They Be A Normal Finding?

9:41 AM - 9:46 AM	Minimal Incisionn Aortic Surgery: An Undertilized But Safe Technique

9:47 AM - 9:55 AM	Panel Discussion Coffee Available In 3rd Floor Foyer
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	43.1 - Current Guidelines For Treatment Of Small AAAs

Web-Based Presentation	43.2 - Debate: Most Type I Endoleaks Are Dangerous And Must Be Treated

Web-Based Presentation	43.3 - Debate: Type I And Type II Endoleaks Are Not Always Dangerous And Some Can Be Observed: Under What Conditions?

END OF SESSION 43

SESSION 44 SCHEDULE
Sunday SESSION 44: NEW DEVELOPMENTS IN DISEASES OF THE SUPRA-AORTIC TRUNKS, THE VERTEBRALS AND THE CAROTIDS (5-MINUTE TALKS) Moderators: / TBD
x
9:56 AM - 10:01 AM	Optimal Treatment For Coincident Carotid Or Vertebral Stenosis And Concurrent High-Grade Intracranial Stenosis

10:02 AM - 10:07 AM	Identifying And Managing The Isolated Cerebral Hemisphere During CAS And CEA

10:08 AM - 10:13 AM	Takayasu’s Disease Treatment Options: When Is Endovascular Treatment With Stenting Acceptable?

10:14 AM - 10:19 AM	Are Stent Fractures After Common Carotid And Innominate Stenting Frequent: When Do They Occur And What Should Be Done About Them?

10:20 AM - 10:25 AM	Long-Term Results Of Vertebral Artery Stenting For Symptomatic Ostial Stenoses: Value And Limitations

10:26 AM - 10:31 AM	Unusual Application Of Flow Reversal Embolic Protection With Vertebral And Other Lesions

10:32 AM - 10:37 AM	Can CEA Be Performed Safely On Patients Taking ASA, Plavix And/Or Coumadin Without Stopping The Drugs: Tips And Tricks

10:38 AM - 10:43 AM	Nationwide US Outcomes For CEA And CAS: Are There Important Differences In Women vs. Men; In Those > 80 vs. Those < 80?

10:44 AM - 10:49 AM	Have CEA Results Improved Since The Landmark Trials (NASCET, ACAS, Etc.) And Why?

10:50 AM - 10:55 AM	Debate 29: There Is A Major Role For CAS In Europe And The USA After The Recent Trials

10:56 AM - 11:01 AM	Debate 29: The Role Of CAS After The Recent Trials Should Be Minimal – Especially In Asymptomatic Patients

11:02 AM - 11:08 AM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	44.1 - Correlation Of Carotid Stump Pressure With Collateral Cerebral Circulation

Web-Based Presentation	44.2 - Does Endovascular Treatment Of Takayasu’s Disease Ever Work And When?

END OF SESSION 44

SESSION 45 SCHEDULE
Sunday SESSION 45: NEW DEVELOPMENTS IN CAS AND RELATED TECHNIQUES (5-MINUTE TALKS) Moderators: / TBD
x
11:09 AM - 11:14 AM	Why All The Landmark Trials Supporting CEA To Prevent Strokes From Carotid Stenosis Are Obsolete: When Is Carotid Intervention Indicated?

11:15 AM - 11:20 AM	Debate 30: CEA Not CAS Is The Best Treatment For Most Patients With High-Grade Carotid Stenosis

11:21 AM - 11:26 AM	Debate 30: CAS Not CEA Is The Best Treatment For Most Patients With High Grade Carotid Stenosis

11:27 AM - 11:32 AM	Debate 30: Best Medical Treatment (BMR_X) Should Be The Treatment Of Choice For Most Patients With Asymptomatic Carotid Stenosis: They Do Not Require Prophylactic CEA Or CAS

11:33 AM - 11:38 AM	CAS vs. CEA: What Are The Relative Results For Symptomatic And Asymptomatic Patients From The SVS Registry?

11:39 AM - 11:44 AM	Debate 31: No Patient Should Undergo CAS Without Embolic Brain Protection

11:45 AM - 11:50 AM	Debate 31: Some Patients Should Undergo CAS Without Embolic Brain Protection

11:51 AM - 11:56 AM	CAS Is The Treatment Of Choice For Post CEA Symptomatic Restenosis: When Is Observation And Medical Treatment Indicated?

11:57 AM - 12:08 PM	Panel Discussion / Refreshments Available In 3rd Floor Foyer
Moderator(s): TBD / TBD
12:09 PM - 12:14 PM	Current Status Of Gra- Scale Median (GSM) For Detecting Asymptomatic Carotid Plaques At Risk For Causing Stroke: Why Is There Controversy About The Value Of GSM In Assessing Plaque Vulnerability And Risk?

12:15 PM - 12:20 PM	Is There A Role For CAS In The Presence Of A Carotid String Sign?

12:21 PM - 12:26 PM	10 Top Tips For CAS Without Complications

12:27 PM - 12:32 PM	Subanalysis Of Flow Reversal System (FRS) For Embolic Protection: What Lessons Can Be Learned?

12:33 PM - 12:38 PM	Comparison Of Filters And Flow Reversal For Brain Protection As Monitored By TCD And DWI MRI

12:39 PM - 12:44 PM	Why Were The Results Of CREST And ICSS So Different: Therapeutic Implications

12:45 PM - 12:50 PM	Analysis Of Filter Debris From CAS Procedures: Does It Correlate With Duplex GSM Findings And How Does It Help Choose The Best Means Of Embolic Protection?

12:51 PM - 12:56 PM	Carotid Stent Fractures: Incidence And Implications

12:57 PM - 1:02 PM	Open Surgical Technique Getting Exposure Of The ICA To The Base Of The Skull For Aneurysms, etc.: It's Better Than Dislocating The Jaw

1:03 PM - 1:10 PM	Panel Discussion
Web-Based Presentation	45.1 - How Can The CREST And ICSS Results Be Reconciled?

Web-Based Presentation	45.2 - SVS CAS Registry Shows No Difference In Results Between Open And Closed Cell Stents

END OF SESSION 45

SESSION 46 SCHEDULE
Sunday SESSION 46: NEW CONCEPTS, ADVANCES, LATE BREAKING TRIALS AND DEVELOPMENTS (4-MINUTE TALKS) Moderators: / TBD
x
1:10 PM - 1:15 PM	Minimal Aortic Injury After Chest Trauma: Not All Patients Need Repair: A New Classification System

1:15 PM - 1:19 PM	Current Thinking About The Biology Of AAAs: Is There Any Hope For Medical Treatment To Slow AAA Growth?
	Presenters(s):Matt M. Thompson, MD
1:20 PM - 1:24 PM	Leaving A Temporary Catheter In The AAA Sac After EVAR Permits Diagnosis And Treatment Of Type I And II Endoleaks

1:25 PM - 1:29 PM	The Unballoon Aortic Dilating Device Improves Endograft Fixation Without Obstructing Flow Or Causing Graft Blow-Down

1:30 PM - 1:34 PM	Preop Variables Predict Which Type II Endoleak Will Persist And Require Reintervention

1:35 PM - 1:39 PM	Improved Techniques For Treating Acute SMA Occlusions In The Endovascular Era

1:40 PM - 1:44 PM	A New Better Prosthetic Vascular Graft That Minimizes Suture Hole Bleeding

1:45 PM - 1:49 PM	What Is The Role For Controlled Hypotension During TEVAR?

1:50 PM - 1:54 PM	The Pin-Down Technique For Crossover Access Via An Aortobifemoral Graft With A Sharp Angle

1:55 PM - 1:59 PM	Long-Term Results Of VAC On Vessel And Prosthesis For The Treatment Of Arterial Graft Infection

2:00 PM - 2:06 PM	Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	46.1 - A New Simplified System For Measuring Internal Pressures Without A Hardwire Connection

Web-Based Presentation	46.2 - Improved Management Of Type II Endoleaks With Coil Embolization

Web-Based Presentation	46.3 - Vascular Injuries From Laparoscopic Procedures: Diagnosis And Treatment

Web-Based Presentation	46.4 - Advantages Of And Indications For Prasugrel Over Plavix For Platelet Inhibition: When Does It Matter?

Web-Based Presentation	46.5 - A New Simplified System To Evacuate Toxic Blood From Ischemic Limbs To Prevent Reperfusion Syndrome After Relief Of Severe Acute Limb Ischemia

Web-Based Presentation	46.6 - New Developments In Silver Acetate Impregnated Grafts For Use In Infected Fields

END OF SESSION 46

SESSION 47 SCHEDULE
Sunday SESSION 47: NEW CONCEPTS, RECENT ADVANCES AND DEVELOPMENTS (4-MINUTE TALKS) Moderators: / / TBD
x
2:07 PM - 2:11 PM	Tips And Tricks For Anterior Lumbar Spine Exposure

2:12 PM - 2:16 PM	Advantages Of Stent-Grafts In TIPS Procedures

2:17 PM - 2:21 PM	Comparison Of Brain Microemboli Resulting From CAS With Flow Reversal And CEA

2:22 PM - 2:26 PM	New Biomarkers Of Activity Levels In Takayasu’s Arteritis: Can They Guide Treatment?

2:27 PM - 2:31 PM	Percutaneous Device (ROX) To Create An Iliac AV Fistula To Improve Oxygenation For Patients With Hypoxic COPD: Status Of European And U.S. Trials

2:32 PM - 2:36 PM	Infrainguinal Bypass Surgery For CLI Has Lower Mortality And Morbidity Than Amputation In Risk Matched Patients

2:37 PM - 2:41 PM	Sideways Movement Of Endografts Is Predictive Of Adverse Events

2:42 PM - 2:46 PM	In Lower Extremity Revascularization How Important Is Patency?

2:47 PM - 2:51 PM	How To Predict Which Patients With A Small AAA Are Likely To Require Treatment

2:52 PM - 2:56 PM	Promising Results Of A Spiral Flow Synthetic Vascular Graft: Theory And 2-Year Fem-Pop Results

2:57 PM - 3:01 PM	Is EVAR The Treatment Of Choice For Aortoenteric Fistulas: Review Of World Experience

3:02 PM - 3:06 PM	The Best Way To Treat Aortoiliac Occlusive Disease Is To Create A New Aortic Bifurcation With Covered Balloon Expandable Stent-Grafts

3:07 PM - 3:11 PM	Role Of PET/CT With FDG Uptake To Assess The Importance Of The Dynamic Inflammatory Process In Arteriosclerosis And How It Can Be Modified By Statins

3:12 PM - 3:19 PM	Panel Discussion
3:19 PM - 3:30 PM	Raffle Prize Drawing For Fully Paid Clinician Attendees. You Must Be Present To Win.
3:30 PM - 3:30 PM	Symposium Ends. Come Back Next Year – November 16-20, 2011.

TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation	47.1 - Is Arterial Compression Underestimated In TOS: Why And What Should Be Done About It?

Web-Based Presentation	47.2 - What Is The 30-Day, 1-Year And 5-Year Mortality For Open AAA Repair In A Northern European Population Based Study? Does Gender Matter?

Web-Based Presentation	47.3 - Anatomic Fixation Of Endografts At The Aortic Bifurcation Enables EVAR Treatment Of Difficult Necks With Good Long-Term Results Without Migration

Web-Based Presentation	47.4 - Predictors Of Cardiac Morbidity And Mortality During EVAR

Web-Based Presentation	47.5 - Endovascular Techniques To Improve Results With Open Repair For Ruptured AAAs

END OF SESSION 47